ck0000885975-10q_20180630.htm

Large accelerated filer

Accelerated filer

Non-accelerated filer

☒ (Do not check if a smaller reporting company)

Smaller reporting company

Emerging growth company

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of July 31, 2018, 1,500 shares of Class A common stock and 182,648 shares of Class B common stock were outstanding.

Certain matters within this Quarterly Report on Form 10Q include “forward–looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The “forward-looking statements” may include our current expectations, assumptions, estimates and projections about our business and our industry. They may include statements relating to future revenues, expenses and profitability, the future development and expected growth of our business, projected capital expenditures, attendance at movies generally or in any of the markets in which we operate, the number or diversity of popular movies released and our ability to successfully license and exhibit popular films, national and international growth in our industry, competition from other exhibitors and alternative forms of entertainment and determinations in lawsuits in which we are defendants. Forward-looking statements can be identified by the use of words such as “may,” “should,” “could,” “estimates,” “predicts,” “potential,” “continue,” “anticipates,” “believes,” “plans,” “expects,” “future” and “intends” and similar expressions. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause the actual results or performance to differ from those projected in the forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. For a description of the risk factors, please review the “Risk Factors” section or other sections in the Company’s Annual Report on Form 10-K filed March 2, 2018 and quarterly reports on Form 10-Q, filed with the Securities and Exchange Commission. All forward-looking statements are expressly qualified in their entirety by such risk factors. We undertake no obligation, other than as required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

	June 30,			December 31,
	2018			2017
Assets
Current assets
Cash and cash equivalents	$	504,695		$	522,415
Inventories		17,685			17,507
Accounts receivable		80,305			89,248
Current income tax receivable		4,815			11,730
Prepaid expenses and other		20,657			16,536
Accounts receivable from parent		18,963			14,581
Total current assets		647,120			672,017

Theatre properties and equipment		3,362,779			3,328,589
Less: accumulated depreciation and amortization		1,545,042			1,500,535
Theatre properties and equipment, net		1,817,737			1,828,054

Other assets
Goodwill		1,281,170			1,284,079
Intangible assets - net		332,506			336,761
Investment in NCM		199,019			200,550
Investments in and advances to affiliates		145,081			120,045
Long-term deferred tax asset		4,050			4,067
Deferred charges and other assets - net		47,488			39,767
Total other assets		2,009,314			1,985,269

Total assets	$	4,474,171		$	4,485,340

Liabilities and equity
Current liabilities
Current portion of long-term debt	$	7,984		$	7,099
Current portion of capital lease obligations		26,671			25,511
Current income tax payable		6,850			5,509
Current liability for uncertain tax positions		3,650			11,873
Accounts payable and accrued expenses		394,279			418,294
Total current liabilities		439,434			468,286

Long-term liabilities
Long-term debt, less current portion		1,774,782			1,780,381
Capital lease obligations, less current portion		239,005			251,151
Long-term deferred tax liability		141,307			121,787
Long-term liability for uncertain tax positions		13,405			8,358
Deferred lease expenses		39,750			40,929
Deferred revenue - NCM		295,264			351,706
Other long-term liabilities		47,462			41,247
Total long-term liabilities		2,550,975			2,595,559

Commitments and contingencies (see Note 16)

Equity
Cinemark USA, Inc.'s stockholder's equity:
Class A common stock, $0.01 par value: 10,000,000 shares authorized, 1,500 shares issued and outstanding		—			—
Class B common stock, no par value: 1,000,000 shares authorized, 239,893 shares issued and 182,648 shares outstanding		49,543			49,543
Treasury stock, 57,245 Class B shares at cost		(24,233	)		(24,233	)
Additional paid-in-capital		1,270,927			1,264,505
Retained earnings		484,453			373,069
Accumulated other comprehensive loss		(309,306	)		(253,282	)
Total Cinemark USA, Inc.'s stockholder's equity		1,471,384			1,409,602
Noncontrolling interests		12,378			11,893
Total equity		1,483,762			1,421,495

Total liabilities and equity	$	4,474,171		$	4,485,340

The accompanying notes are an integral part of the condensed consolidated financial statements.

	Three Months Ended June 30,						Six Months Ended June 30,
	2018			2017			2018			2017
Revenues
Admissions	$	508,870		$	449,880		$	961,494		$	926,349
Concession		305,306			262,322			567,078			530,546
Other		74,877			38,993			140,452			73,910
Total revenues		889,053			751,195			1,669,024			1,530,805
Cost of operations
Film rentals and advertising		287,206			246,556			528,121			499,374
Concession supplies		51,033			41,839			91,857			83,939
Salaries and wages		100,344			89,812			193,502			174,013
Facility lease expense		81,190			82,388			163,281			166,650
Utilities and other		115,602			91,053			225,034			179,410
General and administrative expenses		42,293			37,051			84,024			74,667
Depreciation and amortization		64,290			59,137			128,685			116,493
Impairment of long-lived assets		2,788			4,301			3,379			4,574
Loss on disposal of assets and other		16,901			54			20,840			888
Total cost of operations		761,647			652,191			1,438,723			1,300,008
Operating income		127,406			99,004			230,301			230,797
Other income (expense)
Interest expense		(28,466	)		(26,522	)		(55,581	)		(52,891	)
Loss on debt amendments		—			(246	)		(1,484	)		(246	)
Interest income		2,858			1,380			5,093			2,713
Foreign currency exchange gain (loss)		(5,199	)		(155	)		(3,821	)		1,434
Distributions from NCM		3,424			2,772			9,782			9,560
Interest expense - NCM		(4,913	)		—			(9,892	)		—
Equity in income of affiliates		6,414			5,805			15,050			15,865
Total other expense		(25,882	)		(16,966	)		(40,853	)		(23,565	)

Income before income taxes		101,524			82,038			189,448			207,232
Income taxes		18,502			29,742			43,755			74,370
Net income	$	83,022		$	52,296		$	145,693		$	132,862
Less: Net income attributable to noncontrolling interests		329			571			485			1,037
Net income attributable to Cinemark USA, Inc.	$	82,693		$	51,725		$	145,208		$	131,825

The accompanying notes are an integral part of the condensed consolidated financial statements.

	Three Months Ended June 30,						Six Months Ended June 30,
	2018			2017			2018			2017
Net income	$	83,022		$	52,296		$	145,693		$	132,862
Other comprehensive income (loss), net of tax
Other comprehensive income (loss) in equity method investments		(116	)		(95	)		20			103
Foreign currency translation adjustments		(56,248	)		(18,401	)		(56,044	)		(3,508	)
Total other comprehensive loss, net of tax		(56,364	)		(18,496	)		(56,024	)		(3,405	)
Total comprehensive income, net of tax		26,658			33,800			89,669			129,457
Comprehensive income attributable to noncontrolling interests		(329	)		(571	)		(485	)		(1,037	)
Comprehensive income attributable to Cinemark USA, Inc.	$	26,329		$	33,229		$	89,184		$	128,420

The accompanying notes are an integral part of the condensed consolidated financial statements.

	Six Months Ended June 30,
	2018			2017
Operating activities
Net income	$	145,693		$	132,862
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation		126,981			115,755
Amortization of intangible and other assets and favorable/unfavorable leases		1,704			738
Amortization of long-term prepaid rents		1,236			989
Amortization of debt issue costs		2,913			3,063
Loss on debt amendments		1,484			246
Amortization of deferred revenues, deferred lease incentives and other		(10,762	)		(7,923	)
Impairment of long-lived assets		3,379			4,574
Share based awards compensation expense		6,422			6,051
Loss on disposal of assets and other		20,840			888
Deferred lease expenses		(932	)		(722	)
Equity in income of affiliates		(15,050	)		(15,865	)
Deferred income tax expenses		7,669			14,515
Distributions from equity investees		16,255			14,919
Changes in assets and liabilities and other		(28,187	)		(34,724	)
Net cash provided by operating activities		279,645			235,366
Investing activities
Additions to theatre properties and equipment		(162,589	)		(182,800	)
Acquisitions of theatres in the U.S. and international markets, net of cash acquired		(11,508	)		(40,829	)
Proceeds from sale of theatre properties and equipment and other		2,135			14,521
Investment in joint ventures and other, net		(19,467	)		(466	)
Net cash used for investing activities		(191,429	)		(209,574	)
Financing activities
Dividends paid to parent		(74,350	)		(67,250	)
Payroll taxes paid as a result of stock withholdings		(2,905	)		(2,921	)
Repayments of long-term debt		(3,298	)		(1,427	)
Payment of debt issue costs		(5,103	)		(521	)
Fees paid related to debt amendments		(704	)		(246	)
Payments on capital leases		(12,377	)		(10,143	)
Other		—			(311	)
Net cash used for financing activities		(98,737	)		(82,819	)
Effect of exchange rate changes on cash and cash equivalents		(7,199	)		(75	)
Decrease in cash and cash equivalents		(17,720	)		(57,102	)
Cash and cash equivalents:
Beginning of period		522,415			561,138
End of period	$	504,695		$	504,036
Supplemental information (see Note 13)

The accompanying notes are an integral part of the condensed consolidated financial statements.

Cinemark USA, Inc. and subsidiaries (the “Company”), a wholly-owned subsidiary of Cinemark Holdings, Inc., operates in the motion picture exhibition industry, with theatres in the United States (“U.S.”), Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curacao and Paraguay.

The accompanying condensed consolidated balance sheet as of December 31, 2017, which was derived from audited financial statements, and the unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete consolidated financial statements. In the opinion of management, all adjustments, consisting of normal recurring adjustments, considered necessary for a fair presentation have been included. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and the accompanying notes. Actual results could differ from these estimates. Majority-owned subsidiaries that the Company has control of are consolidated while those affiliates of which the Company owns between 20% and 50% and does not control are accounted for under the equity method. Those affiliates of which the Company owns less than 20% are generally accounted for under the cost method, unless the Company is deemed to have the ability to exercise significant influence over the affiliate, in which case the Company would account for its investment under the equity method. The results of these subsidiaries and affiliates are included in the condensed consolidated financial statements effective with their formation or from their dates of acquisition. Intercompany balances and transactions are eliminated in consolidation.

These condensed consolidated financial statements should be read in conjunction with the audited annual consolidated financial statements and the notes thereto for the year ended December 31, 2017, included in the Annual Report on Form 10-K filed March 2, 2018 by the Company under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Operating results for the three and six months ended June 30, 2018 are not necessarily indicative of the results to be achieved for the full year.

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (Topic 606), (“ASC Topic 606”), which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. ASC Topic 606 replaces most existing revenue recognition guidance in U.S. generally accepted accounting principles. In addition, the standard requires disclosure of the nature, amount, timing, and uncertainty of revenue and cash flows arising from the contracts with customers. The Company adopted ASC Topic 606 effective January 1, 2018. See Note 3 for further discussion.

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), (“ASU 2016-02”). The purpose of ASU 2016-02 is to provide financial statement users a better understanding of the amount, timing, and uncertainty of cash flows arising from leases. The adoption of ASU 2016-02 will result in the recognition of a right-of-use asset and a lease liability for most operating leases. New disclosure requirements include qualitative and quantitative information about the amounts recorded in the financial statements. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018. ASU 2016-02 requires a modified retrospective transition by means of a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year in which the guidance is effective with the option to elect certain practical expedients. Early adoption is permitted. In July 2018, the FASB issued ASU 2018-10, Codification Improvements to Topic 842, Leases, (“ASU 2018-10”). The amendments in ASU 2018-10 provide clarification of narrow aspects of the guidance issued in ASU 2016-02. In July 2018, the FASB issued ASU 2018-11, Leases (Topic 842), Targeted Improvements, (“ASU 2018-11”). The amendments in ASU 2018-11 provide an additional transition method to adopt the amendments in ASU 2016-02. Under this new transition method, an entity initially applies the amendments in ASU 2016-02 at the adoption date and recognizes a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. Under this transition method, an entity is not required to use the modified transition method described in ASU 2016-02. The Company plans to adopt the additional transition method provided in ASU 2018-11. The Company is currently evaluating the impact of ASU 2016-02, ASU 2018-10 and ASU 2018-11 on its condensed consolidated financial statements. The most significant impact of these amendments will be the recognition of new right-of-use assets and lease liabilities for assets related to leased theatres and certain leased equipment that are currently classified as operating leases. The Company will adopt the amendments in ASU 2016-02, ASU 2018-10 and ASU 2018-11 in the first quarter of 2019.

In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments – a consensus of the FASB Emerging Issues Task Force, (“ASU 2016-15”). The purpose of ASU 2016-15 is to

reduce the diversity in practice regarding how certain cash receipts and cash payments are presented and classified in the statement of cash flows. ASU 2016-15 is effective for fiscal years beginning after December 15, 2017, including interim periods within that year. A retrospective transition method should be used in the application of the amendments within ASU 2016-15. The Company adopted ASU 2016-15 effective January 1, 2018. As a result of the adoption of ASU 2016-15, cash paid of $246 related to the June 2017 amendment of the Company’s senior secured credit facility was reclassified from operating activities to financing activities for the six months ended June 30, 2017.

In October 2016, the FASB issued ASU 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory, (“ASU 2016-16”). The purpose of ASU 2016-16 is to improve the accounting for the income tax consequences of intra-entity transfers of assets other than inventory. ASU 2016-16 is effective for fiscal years beginning after December 15, 2017, including interim periods within that year. A modified retrospective transition method should be used in the application of the amendments within ASU 2016-16 with a cumulative-effect adjustment to retained earnings as of the beginning of the period of adoption. ASU 2016-16 did not have a material impact on the Company’s condensed consolidated financial statements.

The Company recognizes admissions and concession revenues when sales are made at the box office and concession stand, respectively. Other revenues include screen advertising, transactional fees and other ancillary revenues such as vendor marketing promotions and meeting rentals located in the Company’s theatres. The Company records proceeds from the sale of gift cards and other advanced sale-type certificates in current liabilities and recognizes admissions or concession revenue when a holder redeems the card or certificate. Additionally, the Company recognizes unredeemed gift cards and other advanced sale-type certificates, as a proportion of actual redemptions, as other revenues, which is an estimate primarily based on the Company’s historical experience with such cards and certificates.

Screen advertising revenues are generally recognized over the period that the related advertising is delivered on-screen or in-theatre. Advances collected on long-term screen advertising, concession and other contracts are recorded as deferred revenues. In accordance with the terms of the agreements, the advances collected on such contracts are recognized during the period in which the Company satisfies the related performance obligations, which may differ from the period in which the advances are collected. These advances are recognized on either a straight-line basis over the term of the contracts or as the Company has met its performance obligations in accordance with the terms of the contracts.

See additional revenue recognition policy considerations, updated for the adoption of ASC Topic 606, below.

The Company adopted ASC 606, Revenue from Contracts with Customers, effective January 1, 2018 under the modified retrospective method (cumulative-effect) and therefore, revenue amounts as presented on the condensed consolidated statements of income have not been adjusted for prior periods presented.

Changes to the way in which the Company recognizes revenue resulted in the following impacts to the condensed consolidated statements of income:

The above noted changes increased (decreased) admissions, concession and other revenue for the three and six months ended June 30, 2018 as follows:

The Company applied the practical expedient to exclude sales and other similar taxes collected from customers from its transaction price for purposes of recording revenues, as such revenues are presented net of such taxes.

The following table presents revenues for the three and six months ended June 30, 2018, disaggregated based on major type of good or service and by reportable operating segment.

	Three Months Ended						Six Months Ended
	June 30, 2018						June 30, 2018
	U.S.		International				U.S.		International
	Operating		Operating				Operating		Operating
Major Goods/Services	Segment ⁽¹⁾		Segment		Consolidated		Segment ⁽¹⁾		Segment		Consolidated
Admissions revenues	$	408,863	$	100,007	$	508,870	$	758,215	$	203,279	$	961,494
Concession revenues		249,618		55,688		305,306		453,368		113,710		567,078
Screen advertising and promotional revenues		21,051		15,446		36,497		39,230		29,715		68,945
Other revenues		29,542		8,838		38,380		54,604		16,903		71,507
Total revenues	$	709,074	$	179,979	$	889,053	$	1,305,417	$	363,607	$	1,669,024

The following table presents revenues for the three and six months ended June 30, 2018, disaggregated based on timing of revenue recognition (see Revenue Recognition Policy above).

	Three Months Ended						Six Months Ended
	June 30, 2018						June 30, 2018

	U.S.		International				U.S.		International
	Operating		Operating				Operating		Operating
	Segment ⁽¹⁾		Segment		Consolidated		Segment ⁽¹⁾		Segment		Consolidated
Goods and services transferred at a point in time	$	686,463	$	161,350	$	847,813	$	1,262,289	$	327,499	$	1,589,788
Goods and services transferred over time		22,611		18,629		41,240		43,128		36,108		79,236
Total	$	709,074	$	179,979	$	889,053	$	1,305,417	$	363,607	$	1,669,024

The following table presents changes in the Company’s deferred revenues for the six months ended June 30, 2018.

The table below summarizes the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied as of June 30, 2018 and when the Company expects to recognize this revenue.

Accounts receivable as of June 30, 2018 included approximately $48,631 of receivables related to contracts with customers. The Company did not record any assets related to the costs to obtain or fulfill a contract with customers during the six months ended June 30, 2018.

As discussed further in Note 6, in connection with the completion of the NCM, Inc. (“NCMI”) initial public offering, the Company amended and restated its ESA with NCM and received approximately $174,000 in cash consideration from NCM. The proceeds were recorded as deferred revenue and are being amortized over the term of the modified ESA, or through February 2037. In addition to the consideration received upon the ESA modification during 2007, the Company also receives consideration in the form of common units from NCM, at each annual common unit adjustment settlement, in exchange for exclusive access to the Company’s newly opened domestic screens under the ESA. See Note 6 for additional information regarding the common unit adjustment and related accounting. Due to the significant length of time between receiving the consideration from NCM and fulfillment of the related performance obligation, the ESA includes an implied significant financing component, as per the guidance in ASC Topic 606.

As a result of the significant financing component on deferred revenue - NCM, the Company recognized incremental screen advertising revenue and an offsetting interest expense of $4,913 and $9,892 during the three and six months ended June 30, 2018, respectively. The interest expense was calculated using the Company’s incremental borrowing rates at the time when the cash and each tranche of common units were received from NCM, which ranged from 5.5% to 8.0%.

On March 29, 2018, the Company amended its senior secured credit facility to extend the maturity of the term loan to March 29, 2025, reduce the rate at which the term loan bears interest by 0.25% and to reduce the amount of real property required to be mortgaged to secure the loans. Under the amended facility, quarterly principal payments of $1,649 are due on the term loan through December 31, 2024, with a final principal payment of $613,351 due on March 29, 2025. The Company incurred debt issue costs of

approximately $4,962 in connection with the amendment, which are reflected as a reduction of long term debt on the condensed consolidated balance sheet as of June 30, 2018. As a result of the amendment, the Company wrote-off $780 of unamortized debt issue costs and incurred approximately $704 in legal and other fees, both of which are reflected as loss on debt amendments on the condensed consolidated statements of income for the six months ended June 30, 2018.

The Company estimates the fair value of its long-term debt using the market approach, which utilizes quoted market prices that fall under Level 2 of the U.S. GAAP fair value hierarchy as defined by ASC 820, Fair Value Measurement (“ASC Topic 820”). The carrying value of the Company’s long-term debt was $1,813,997 and $1,817,295 as of June 30, 2018 and December 31, 2017, respectively, excluding unamortized debt discounts and debt issue costs. The fair value of the Company’s long-term debt was $1,800,830 and $1,840,918 as of June 30, 2018 and December 31, 2017, respectively.

Below is a summary of changes in stockholder’s equity attributable to Cinemark USA, Inc., noncontrolling interests and total equity for the six months ended June 30, 2018 and 2017:

	Cinemark
	USA, Inc.
	Stockholder’s			Noncontrolling		Total
	Equity			Interests		Equity
Balance at January 1, 2018	$	1,409,602		$	11,893	$	1,421,495
Cumulative effect of change in accounting principle, net of taxes of $13,079 (see Note 3)		40,526			—		40,526
Share based awards compensation expense		6,422			—		6,422
Dividends paid to parent		(74,350	)		—		(74,350	)
Net income		145,208			485		145,693
Other comprehensive income in equity method investees		20			—		20
Foreign currency translation adjustments		(56,044	)		—		(56,044	)
Balance at June 30, 2018	$	1,471,384		$	12,378	$	1,483,762


	Cinemark
	USA, Inc.
	Stockholder’s			Noncontrolling			Total
	Equity			Interests			Equity
Balance at January 1, 2017	$	1,272,938		$	11,142		$	1,284,080
Share based awards compensation expense		6,051		―				6,051
Dividends paid to parent		(67,250	)	―				(67,250	)
Dividends paid to noncontrolling interests	―				(294	)		(294	)
Net income		131,825			1,037			132,862
Other comprehensive income in equity method investees		103		―				103
Foreign currency translation adjustments		(5,059	)	―				(5,059	)
Balance at June 30, 2017	$	1,338,608		$	11,885		$	1,350,493

The Company has an investment in National Cinemedia, LLC (“NCM”). NCM operates a digital in-theatre network in the U.S. for providing cinema advertising. Upon joining NCM, the Company entered into an Exhibitor Services Agreement with NCM (“ESA”), pursuant to which NCM provides advertising and promotions to our theatres. As described further in Note 3 to the Company’s financial statements as included in its 2017 Annual Report on Form 10-K, on February 13, 2007, National Cinemedia, Inc. (“NCMI”), an entity that serves as the sole manager of NCM, completed an initial public offering (“IPO”) of its common stock. In connection with the NCMI initial public offering, the Company amended its operating agreement and the ESA. Following the NCM, Inc. IPO, the Company does not recognize undistributed equity in the earnings on its original NCM membership units (referred to herein as the Company’s Tranche 1 Investment) until NCM’s future net earnings, less distributions received, surpass the amount of the excess distribution. The Company recognizes equity in earnings on its Tranche 1 Investment only to the extent it receives cash distributions from NCM. The Company recognizes cash distributions it receives from NCM on its Tranche 1 Investment as a

component of earnings as Distributions from NCM. The Company believes that the accounting model provided by ASC Topic 323-10-35-22 for recognition of equity investee losses in excess of an investor’s basis is analogous to the accounting for equity income subsequent to recognizing an excess distribution.

Below is a summary of activity with NCM included in the Company’s condensed consolidated financial statements:

	Investment in NCM			Deferred Revenue			Distributions from NCM			Equity in Earnings			Other Revenue			Interest Expense - NCM (3)		Cash Received
Balance as of January 1, 2018	$	200,550		$	(351,706	)
Impact of adoption of ASC Topic 606 ⁽¹⁾		—			53,605		$	—		$	—		$	—		$	—	$	—
Receipt of common units due to annual common unit adjustment ("CUA")		5,012			(5,012	)		—			—			—			—		—
Revenues earned under ESA ^{(2) (3)}		—			—			—			—			(16,074	)		9,892		6,182
Receipt of excess cash distributions		(8,760	)		—			(7,735	)		—			—			—		16,495
Receipt under tax receivable agreement		(2,294	)		—			(2,047	)		—			—			—		4,341
Equity in earnings		4,511			—			—			(4,511	)		—			—		—
Amortization of deferred revenue		—			7,849			—			—			(7,849	)		—		—
Balance as of and for the six months ended June 30, 2018	$	199,019		$	(295,264	)	$	(9,782	)	$	(4,511	)	$	(23,923	)	$	9,892	$	27,018

During the three months ended June 30, 2018 and 2017, the Company recorded equity in earnings of $495 and $176, respectively. During the six months ended June 30, 2018 and 2017, the Company recorded equity in earnings of $4,511 and $3,065, respectively.

The Company made payments to NCM of $60 and $50 during the six months ended June 30, 2018 and 2017, respectively, related to installation of certain equipment used for digital advertising, which is included in theatre properties and equipment on the condensed consolidated balance sheets.

Pursuant to a Common Unit Adjustment Agreement dated as of February 13, 2007 between NCMI and the Company, AMC Entertainment, Inc. (“AMC”) and Regal Entertainment Group (“Regal”) (collectively, “Founding Members”), annual adjustments to the common membership units are made primarily based on increases or decreases in the number of theatre screens operated and theatre attendance generated by each Founding Member. As further discussed in Note 3 to the Company’s financial statements as included in its 2017 Annual Report on Form 10-K, the common units received (collectively referred to as the Company’s “Tranche 2 Investment”) are recorded at estimated fair value as an increase in the Company’s investment in NCM with an offset to deferred revenue. The Company’s Tranche 2 Investment is accounted for following the equity method, with undistributed equity earnings related to its Tranche 2 Investment included as a component of earnings in equity in income of affiliates and distributions received related to its Tranche 2 Investment are recorded as a reduction of investment basis.

During March 2018, NCM performed its annual common unit adjustment calculation under the Common Unit Adjustment Agreement. As a result of the calculation, on March 29, 2018, the Company received an additional 908,042 common units of NCM, each of which is convertible into one share of NCMI common stock. The Company recorded the additional common units received at estimated fair value with a corresponding adjustment to deferred revenue of approximately $5,012. The fair value of the common units received was estimated based on the market price of NCMI common stock at the time the common units were determined, adjusted for volatility associated with the estimated time period it would take to convert the common units and register the respective shares. The deferred revenue will be recognized on a straight-line basis over the remaining term of the ESA, which is approximately 19 years.

As of June 30, 2018, the Company owned a total of 28,779,904 common units of NCM, representing an ownership interest of approximately 18%. The estimated fair value of the Company’s investment in NCM was approximately $241,751 based on the price of NCMI common stock as of June 30, 2018 of $8.40 per share (Level 1 input as defined in FASB ASC Topic 820). See Note 17 for discussion of subsequent event related to the acquisition of additional NCM common units from AMC.

Below is a summary of activity for each of the Company’s other investments for the six months ended June 30, 2018:

	DCIP			AC JV, LLC		DCDC			FE Concepts			Other		Total
Balance at January 1, 2018	$	106,215		$	5,916	$	3,598		$	104		$	4,212	$	120,045
Cash contributions made		739			—		—			20,000					20,739
Cash distributions received		(5,201	)		—		—			—			—		(5,201	)
Equity in income (loss)		9,727			408		481			(77	)		—		10,539
Equity in other comprehensive income		20			—		—			—			—		20
Other		—			—		(1,168	)		(104	)		211		(1,061	)
Balance at June 30, 2018	$	111,500		$	6,324	$	2,911		$	19,923		$	4,423	$	145,081

On February 12, 2007, the Company, AMC and Regal entered into a joint venture known as DCIP to facilitate the implementation of digital cinema in the Company’s theatres and to establish agreements with major motion picture studios for the financing of digital cinema. As of June 30, 2018, the Company had a 33% voting interest in DCIP and a 24.3% economic interest in DCIP. The Company accounts for its investment in DCIP and its subsidiaries under the equity method of accounting.

As of June 30, 2018, the Company had 3,818 digital projection systems being leased under the master equipment lease agreement with Kasima LLC, which is an indirect subsidiary of DCIP and a related party to the Company. The Company had the following transactions with DCIP, reflected in utilities and other costs on the condensed consolidated statements of income, during the three and six months ended June 30, 2018 and 2017:

During December 2013, the Company, Regal, AMC (the “AC Founding Members”) and NCM entered into a series of agreements that resulted in the formation of AC JV, LLC (“AC”), a joint venture that owns “Fathom Events” formerly operated by NCM. The Fathom Events business focuses on the marketing and distribution of live and pre-recorded entertainment programming to various theatre operators, including concerts, opera and symphony, DVD product releases and marketing events, theatrical premieres, Broadway plays, live sporting events and other special events. The Company paid event fees to AC of $5,588 and $6,763 for the six months ended June 30, 2018 and 2017, respectively, which are included in film rentals and advertising costs on the condensed consolidated statements of income. Additionally, the remaining outstanding balance of a note payable from the Company to NCM, related to the formation of AC, was $2,778 as of June 30, 2018.

Digital Cinema Distribution Coalition (“DCDC”) is a joint venture among the Company, Universal, Warner Bros., AMC and Regal. DCDC operates a satellite distribution network that distributes all digital content to U.S. theatres via satellite. The Company has an approximate 14.6% ownership in DCDC. The Company paid approximately $461 and $446 to DCDC during the six months ended June 30, 2018 and 2017, respectively, related to content delivery services provided by DCDC. These fees are included in film rentals and advertising costs on the condensed consolidated statements of income.

During April 2018, the Company, through its wholly-owned indirect subsidiary CNMK Texas Properties, LLC (“CNMK”), formed a joint venture, FE Concepts, LLC (“FE Concepts”) with AWSR Investments, LLC (“AWSR”), an entity owned by Lee Roy Mitchell and Tandy Mitchell. FE Concepts will develop and operate a family entertainment center that offers bowling, gaming, movies and other amenities. The Company and AWSR each invested approximately $20,000 and each have a 50% voting interest in FE Concepts. The Company accounts for its investment in FE Concepts under the equity method of accounting.

Restricted Stock – During the six months ended June 30, 2018, Cinemark Holdings, Inc. granted 321,406 shares of restricted stock to its directors and employees of the Company. The fair value of the restricted stock granted was determined based on the market value of Cinemark Holdings, Inc.’s common stock on the dates of grant, which ranged from $35.81 to $39.26 per share. The Company assumed forfeiture rates ranging from 0% to 10% for the restricted stock awards. The restricted stock awards vest over periods ranging from one to four years. The recipients of restricted stock are entitled to receive non-forfeitable dividends and to vote their respective shares, however, the sale and transfer of the restricted shares is prohibited during the restriction period.

Below is a summary of restricted stock activity for the six months ended June 30, 2018:

As of June 30, 2018, the estimated remaining unrecognized compensation expense related to unvested restricted stock awards was $19,408, of which $18,528 will be recognized by the Company and $880 will be recognized by Cinemark Holdings, Inc. The weighted average period over which this remaining compensation expense will be recognized is approximately two years.

Restricted Stock Units – During the six months ended June 30, 2018, Cinemark Holdings, Inc. granted restricted stock units representing 228,194 hypothetical shares of its common stock to employees of the Company. The restricted stock units vest based on a combination of financial performance factors and continued service. The financial performance factors are based on an implied equity value concept that determines an internal rate of return (“IRR”) during the two fiscal year periods ending December 31, 2019 based on a formula utilizing a multiple of Adjusted EBITDA subject to certain adjustments as specified by the Compensation Committee of Cinemark Holdings, Inc.’s board of directors prior to the grant date. The financial performance factors for the restricted stock units have a threshold, target and maximum level of payment opportunity and vest on a prorata basis according to the IRR achieved by the Company during the performance period. If the IRR for the two-year period is at least 7%, which is the threshold, one-third of the maximum restricted stock units vest. If the IRR for the two-year period is at least 9.5%, which is the target, two-thirds of the maximum restricted stock units vest. If the IRR for the two-year period is at least 13%, which is the maximum, 100% of the maximum restricted stock units vest. Grantees are eligible to receive a ratable portion of the common stock issuable if the IRR is within the targets previously noted. Further, as an example, if the Company achieves an IRR equal to 11%, the number of restricted stock units that shall vest will be greater than the target but less than the maximum number that would have vested had the Company achieved the highest IRR. All restricted stock units granted during 2018 will vest subject to an additional two-year service requirement and will be paid in the form of Cinemark Holdings, Inc.’s common stock if the participant continues to provide services through the fourth anniversary of the grant date. Restricted stock unit award participants are eligible to receive dividend equivalent payments from the grant date if, and at the time that, the restricted stock unit awards vest.

Below is a table summarizing the potential number of shares that could vest under restricted stock unit awards granted during the six months ended June 30, 2018 at each of the three target levels of financial performance (excluding forfeiture assumptions):

Due to the fact that the IRR for the two-year performance period could not be determined at the time of the 2018 grant, the Company estimated that the most likely outcome is the achievement of the target IRR level. The fair value of the restricted stock unit awards was determined based on the closing price of Cinemark Holdings, Inc.’s common stock on the dates of grant, which ranged from $37.55 to $39.03 per share. The Company assumed forfeiture rates ranging from 0% to 5% for the restricted stock unit awards. If during the service period, additional information becomes available to lead the Company to believe a different IRR level will be achieved for the two-year performance period, the Company will reassess the number of units that are expected to vest for the grant and adjust its compensation expense accordingly on a prospective basis over the remaining service period.

During the six months ended June 30, 2018, the Company determined that the IRR reached for the restricted stock units granted in February 2016 was 7.2%, compared to a target IRR of 8.0%. The Company recorded a reduction in compensation expense of $69 during the six months ended June 30, 2018 to reflect the revised number of shares expected to vest in February 2020 for the 2016 restricted stock unit grant.

As of June 30, 2018, the estimated remaining unrecognized compensation expense related to the outstanding restricted stock unit awards was $9,854. The weighted average period over which this remaining compensation expense will be recognized is approximately two years. As of June 30, 2018, the Company had restricted stock units outstanding that represented a total of 594,266 hypothetical shares of Cinemark Holdings, Inc.’s common stock, net of actual cumulative forfeitures of 18,667 units, assuming an IRR of 7.2% was achieved for the 2016 grants and the maximum IRR level is achieved for all other grants outstanding.

The Company evaluates goodwill for impairment annually during the fourth quarter or whenever events or changes in circumstances indicate the carrying value of the goodwill may not be fully recoverable. The Company evaluates goodwill for impairment at the reporting unit level and has allocated goodwill to the reporting unit based on an estimate of its relative fair value. Management considers the reporting unit to be each of its nineteen regions in the U.S. and seven countries internationally with Honduras, El Salvador, Nicaragua, Costa Rica, Panama and Guatemala considered one reporting unit (the Company does not have goodwill recorded for all of its international locations). For the year ended December 31, 2017, the Company performed a quantitative goodwill impairment assessment on all reporting units, in accordance with ASC Topic 350-20-35. No events or changes in circumstances occurred during the six months ended June 30, 2018 that indicated the carrying value of goodwill might exceed its estimated fair value.

	Balance at											Balance at
	January 1,											June 30,
	2018			Additions ⁽¹⁾		Amortization			Other ⁽²⁾			2018
Intangible assets with finite lives:
Gross carrying amount	$	105,895		$	—	$	—		$	(1,645	)	$	104,250
Accumulated amortization		(68,869	)	―			(2,932	)	―				(71,801	)
Total net intangible assets with finite lives	$	37,026		$	—	$	(2,932	)	$	(1,645	)	$	32,449

Intangible assets with indefinite lives:
Tradename and other		299,735			608	―				(286	)		300,057
Total intangible assets — net	$	336,761		$	608	$	(2,932	)	$	(1,931	)	$	332,506

For the year ended December 31, 2017, the Company performed a quantitative assessment for all definite and indefinite-lived tradename assets. No events or changes in circumstances occurred during the six months ended June 30, 2018 that indicated the carrying value of its tradename assets might exceed their estimated fair values.

Estimated aggregate future amortization expense for intangible assets is as follows:

The Company reviews long-lived assets for impairment indicators on a quarterly basis or whenever events or changes in circumstances indicate the carrying amount of the assets may not be fully recoverable. See discussion of the Company’s long-lived asset impairment evaluation process in Note 1 to the Company’s financial statements as included in its 2017 Annual Report on Form 10-K. As noted in the discussion, fair value is determined based on a multiple of cash flows, which was six and a half times for the evaluations performed during the six months ended June 30, 2018 and 2017. As of June 30, 2018, the estimated aggregate fair value of the long-lived assets impaired during the six months ended June 30, 2018 was $871.

The long-lived asset impairment charges recorded during each of the periods presented are specific to theatres that were directly and individually impacted by increased competition, adverse changes in market demographics or adverse changes in the development or the conditions of the areas surrounding the theatre.

The Company determines fair value measurements in accordance with ASC Topic 820, which establishes a fair value hierarchy under which an asset or liability is categorized based on the lowest level of input significant to its fair value measurement. The levels of input defined by ASC Topic 820 are as follows:

Level 1 – quoted market prices in active markets for identical assets or liabilities that are accessible at the measurement date;

Level 2 – other than quoted market prices included in Level 1 that are observable for the asset or liability, either directly or indirectly; and

Level 3 – unobservable and should be used to measure fair value to the extent that observable inputs are not available.

The Company did not have any assets or liabilities measured at fair value on a recurring basis under ASC Topic 820 as of December 31, 2017 or June 30, 2018.

The Company uses the market approach for fair value measurements on a nonrecurring basis in the impairment evaluations of its long-lived assets (see Note 9 and Note 10). See additional explanation of fair value measurement techniques used for long-lived assets, goodwill and intangible assets in “Critical Accounting Policies” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2017, filed March 2, 2018. There were no changes in valuation techniques and there were no transfers in or out of Level 1, Level 2 or Level 3 during the six months ended June 30, 2018.

The accumulated other comprehensive loss account in stockholder’s equity of $309,306 and $253,282 as of June 30, 2018 and December 31, 2017, respectively, primarily includes cumulative foreign currency adjustments of $309,609 and $253,565, respectively, from translating the financial statements of the Company’s international subsidiaries.

As of June 30, 2018, all foreign countries where the Company has operations are non-highly inflationary, and the local currency is the same as the functional currency in all of the locations. Thus, any fluctuation in the currency results in a cumulative foreign currency translation adjustment recorded to accumulated other comprehensive loss.

A highly inflationary economy is defined as an economy with a cumulative inflation rate of approximately 100 percent or more over a three-year period. If a country’s economy is classified as highly inflationary, the financial statements of the foreign entity operating in that country must be remeasured to the functional currency of the reporting entity. There has been a steady devaluation of the Argentine peso relative to the U.S. dollar in recent years. As of June 30, 2018, the Company did not designate Argentina as highly inflationary for accounting purposes. However, the Company has determined that Argentina will be deemed highly inflationary beginning July 1, 2018. The financial information of the Company’s Argentina subsidiaries will be remeasured in U.S. dollars in accordance with ASC Topic 830, Foreign Currency Matters, effective July 1, 2018.

Below is a summary of the impact of translating the June 30, 2018 financial statements of the Company’s international subsidiaries:

The following is provided as supplemental information to the condensed consolidated statements of cash flows:

The Company manages its international market and its U.S. market as separate reportable operating segments, with the international segment consisting of operations in Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curacao and Paraguay. Each segment’s revenue is derived from admissions and concession sales and other ancillary revenues. The Company uses Adjusted EBITDA, as shown in the reconciliation table below, as the primary measure of segment profit and loss to evaluate performance and allocate its resources. The Company does not report total assets by segment because that information is not used to evaluate the performance of or allocate resources between segments.

Below is a breakdown of selected financial information by reportable operating segment:

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2018			2017			2018			2017
Revenues
U.S.	$	712,483		$	554,929		$	1,312,128		$	1,136,138
International		179,979			199,926			363,607			401,994
Eliminations		(3,409	)		(3,660	)		(6,711	)		(7,327	)
Total revenues	$	889,053		$	751,195		$	1,669,024		$	1,530,805

Adjusted EBITDA
U.S.	$	188,920		$	129,976		$	345,190		$	295,038
International		33,192			41,285			70,778			88,511
Total Adjusted EBITDA	$	222,112		$	171,261		$	415,968		$	383,549

Capital expenditures
U.S.	$	59,675		$	77,175		$	129,646		$	155,992
International		22,751			14,438			32,943			26,808
Total capital expenditures	$	82,426		$	91,613		$	162,589		$	182,800

The following table sets forth a reconciliation of net income to Adjusted EBITDA:

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2018			2017			2018			2017
Net income	$	83,022		$	52,296		$	145,693		$	132,862
Add (deduct):		-			-
Income taxes		18,502			29,742			43,755			74,370
Interest expense ⁽¹⁾		28,466			26,522			55,581			52,891
Other (income) expense ⁽²⁾		840			(7,030	)		(6,430	)		(20,012	)
Loss on debt amendments		—			246			1,484			246
Other cash distributions from equity investees ⁽³⁾		3,932			2,870			16,255			14,919
Depreciation and amortization		64,290			59,137			128,685			116,493
Impairment of long-lived assets		2,788			4,301			3,379			4,574
Loss on disposal of assets and other		16,901			54			20,840			888
Deferred lease expenses		(449	)		(375	)		(932	)		(722	)
Amortization of long-term prepaid rents		597			496			1,236			989
Share based awards compensation expense		3,223			3,002			6,422			6,051
Adjusted EBITDA	$	222,112		$	171,261		$	415,968		$	383,549

The Company manages theatres for Laredo Theatre, Ltd. (“Laredo”). The Company is the sole general partner and owns 75% of the limited partnership interests of Laredo. Lone Star Theatres, Inc. owns the remaining 25% of the limited partnership interests in Laredo and is 100% owned by Mr. David Roberts, Lee Roy Mitchell’s son-in-law. Lee Roy Mitchell is Cinemark Holdings, Inc.’s Chairman of the Board of Directors and directly and indirectly owns approximately 8% of Cinemark Holdings, Inc.’s common stock. Under the agreement, management fees are paid by Laredo to the Company at a rate of 5% of annual theatre revenues up to $50,000 and 3% of annual theatre revenues in excess of $50,000. The Company recorded $327 and $305 of management fee revenues during the six months ended June 30, 2018 and 2017, respectively. All such amounts are included in the Company’s condensed consolidated financial statements with the intercompany amounts eliminated in consolidation.

The Company has an Aircraft Time Sharing Agreement with Copper Beech Capital, LLC (“Copper Beech”) to use, on occasion, a private aircraft owned by Copper Beech. Copper Beech is owned by Mr. Mitchell and his wife, Tandy Mitchell. The private aircraft is used by Mr. Mitchell and other executives who accompany Mr. Mitchell to business meetings for the Company. The Company reimburses Copper Beech for the actual costs of fuel usage and the expenses of the pilots, landing fees, storage fees and similar expenses incurred during the trip. For the six months ended June 30, 2018 and 2017, the aggregate amounts paid to Copper Beech for the use of the aircraft was $51 and $63, respectively.

The Company leases 14 theatres and one parking facility from Syufy Enterprises, LP (“Syufy”) or affiliates of Syufy. Raymond Syufy is one of Cinemark Holdings, Inc.’s directors and is an officer of the general partner of Syufy. Of these 15 leases, 14 have fixed minimum annual rent. The one lease without minimum annual rent has rent based upon a specified percentage of gross sales as defined in the lease. For the six months ended June 30, 2018 and 2017, the Company paid total rent of approximately $12,980 and $13,420, respectively, to Syufy.

The Company has paid certain fees on behalf of its parent, Cinemark Holdings, Inc., and Cinemark Holdings, Inc. has paid income taxes and other items on behalf of the Company. The net receivable from Cinemark Holdings, Inc. as of June 30, 2018 and December 31, 2017 was $18,963 and $14,581, respectively. The Company paid Cinemark Holdings, Inc. cash dividends of $74,350 and $67,250 during the six months ended June 30, 2018 and 2017, respectively.

The Company has a 50% voting interest in FE Concepts, a joint venture with AWSR, an entity owned by Lee Roy Mitchell and Tandy Mitchell. FE Concepts will develop and operate a family entertainment center that offers bowling, gaming, movies and other amenities. See Note 7 for further discussion.

Joseph Amey, et al. v. Cinemark USA, Inc., Case No. 3:13cv05669, In the United States District Court for the Northern District of California, San Francisco Division. The case presents putative class action claims for penalties and attorney's fees arising from alleged violations of the California wage statement law. The claim is also asserted as a representative action under the California Private Attorney General Act (PAGA) for penalties. The company denies the claims, denies that class certification is appropriate, denies that the plaintiff has standing to assert the claims alleged and is vigorously defending against the claims. The company denies any violation of law and plans to vigorously defend against all claims. The parties are awaiting the Court's ruling on Plaintiff's motion for class certification. The Company is unable to predict the outcome of this litigation or the range of potential loss.

Flagship Theatres of Palm Desert, LLC d/b/a Cinemas Palme D’Or v. Century Theatres, Inc., and Cinemark USA, Inc.; Superior Court of the State of California, County of Los Angeles. Plaintiff in this case alleges that the Company violated California antitrust and unfair competition laws by engaging in “circuit dealing” with various motion picture distributors and tortuously interfered with Plaintiff’s business relationships. Plaintiff seeks compensatory damages, trebling of those damages under California law, punitive damages, injunctive relief, attorneys’ fees, costs and interest. Plaintiff also alleges that the Company’s conduct ultimately resulted in closure of its theatre in June 2016. The Company denied the allegations. In 2008, the Company moved for summary judgment on Plaintiff’s claims, arguing primarily that clearances between the theatres at issue were lawful and that Plaintiff lacked proof sufficient to support certain technical elements of its antitrust claims. The trial court granted that motion and dismissed Plaintiff’s claims. Plaintiff appealed and, in 2011, the Court of Appeal reversed, holding, among other things, that Plaintiff’s claims were not about the illegality of clearances but were focused, instead, on “circuit dealing.” Having re-framed the claims in that manner, the Court of Appeal held that the trial court’s decision to limit discovery to the market where the theatres at issue operated was an error, as “circuit dealing” necessarily involves activities in different markets. Upon return to the trial court, the parties engaged in additional, broadened discovery related to Plaintiff’s “circuit dealing” claim. Thereafter, the Company moved again for summary judgment on all of Plaintiff’s claims. That new motion for summary judgment was pending when, on or about April 11, 2014, the trial court granted the Company’s motion for terminating sanctions and entered a judgment dismissing the case with prejudice. Plaintiff then appealed that second dismissal, seeking to have the judgment reversed and the case remanded to the trial court. The Court of Appeal issued a ruling on May 24, 2016, reversing the granting of terminating sanctions and instead imposed a lesser evidentiary and damages preclusion sanction. The case returned to the trial court on October 6, 2016. On May 10, 2018, after a five-week jury trial, the jury found no liability on one circuit dealing claim and awarded Plaintiff damages on the other claim, which are tripled for antitrust damage awards. Plaintiff would also be entitled to certain court costs and to seek at least some portion of its attorney’s fees. During the three and six months ended June 30, 2018, the Company recorded a litigation reserve based on an estimate of the jury award, which is reflected in loss on disposal of assets and other on the condensed consolidated income statement. The Company has filed a motion for a judgment notwithstanding the verdict and a motion for a new trial. Depending on the ruling on these motions, the Company intends to appeal any final judgment. Although the Company denies that it engaged in any form of circuit dealing, it cannot predict the outcome of its pending motions or future appeals.

The Company received a Civil Investigative Demand (“CID”) from the Antitrust Division of the United States Department of Justice. The CID relates to an investigation under Sections 1 and 2 of the Sherman Act. The Company also received CIDs from the Antitrust Section of the Office of the Attorney General of the State of Ohio and later from other states regarding similar inquiries under state antitrust laws. The CIDs request the Company to answer interrogatories, and produce documents, or both, related to the investigation of matters including film clearances, potential coordination and/or communication with other major theatre circuits and related joint ventures. The Company intends to fully cooperate with all federal and state government agencies. Although the Company does not believe that it has violated any federal or state antitrust or competition laws, it cannot predict the ultimate scope, duration or outcome of these investigations.

From time to time, the Company is involved in various other legal proceedings arising from the ordinary course of its business operations, such as personal injury claims, employment matters, landlord-tenant disputes, patent claims and contractual disputes, some of which are covered by insurance. The Company believes its potential liability with respect to proceedings currently pending is not material, individually or in the aggregate, to the Company’s financial position, results of operations and cash flows.

On July 5, 2018 the Company acquired 10,738,740 common units of NCM from AMC for $78,400 in cash, or approximately $7.30 per common unit. As a result of the acquisition of these shares, the Company’s ownership of NCM increased from approximately 18% to 25%. The amount paid for the additional common units will be recorded as an increase in the Company’s investment in NCM. See Note 6 for further discussion of the accounting for the Company’s investment in NCM.

As of June 30, 2018, the Company had outstanding $400,000 aggregate principal amount of 5.125% senior notes due 2022, or the 5.125% Senior Notes, and $755,000 aggregate principal amount of 4.875% senior notes due 2023, or the 4.875% Senior Notes, (collectively the “Notes”). These Notes are fully and unconditionally guaranteed on a joint and several senior unsecured basis by the following subsidiaries of Cinemark USA, Inc.:

Sunnymead Cinema Corp., Cinemark Properties, Inc., Greeley Holdings, Inc., Cinemark Partners I, Inc., CNMK Investments, Inc., CNMK Texas Properties, LLC., Cinemark Concessions LLC, Century Theatres, Inc., Marin Theatre Management, LLC, Century Theatres NG, LLC, Cinearts LLC, Cinearts Sacramento, LLC, Corte Madera Theatres, LLC, Novato Theatres, LLC, San Rafael Theatres, LLC, Northbay Theatres, LLC, Century Theatres Summit Sierra, LLC and Century Theatres Seattle, LLC.

The following supplemental condensed consolidating financial information presents:

	Parent		Subsidiary		Subsidiary
	Company		Guarantors		Non-Guarantors		Eliminations			Consolidated

Assets
Current assets
Cash and cash equivalents	$	130,590	$	180,623	$	211,202	$	—		$	522,415
Other current assets		59,661		17,841		76,789		(19,270	)		135,021
Accounts receivable from parent or subsidiaries		117,972		119,616		—		(223,007	)		14,581
Total current assets		308,223		318,080		287,991		(242,277	)		672,017
Theatre properties and equipment - net		650,783		765,500		411,771		—			1,828,054
Investment in subsidiaries		1,691,626		121,795		—		(1,813,421	)		—
Other assets		1,427,328		134,845		536,816		(113,720	)		1,985,269
Total assets	$	4,077,960	$	1,340,220	$	1,236,578	$	(2,169,418	)	$	4,485,340
Liabilities and equity
Current liabilities
Current portion of long-term debt	$	5,710	$	—	$	1,389	$	—		$	7,099
Current portion of capital lease obligations		9,532		11,124		4,855		—			25,511
Accounts payable and accrued expenses		215,580		116,409		110,089		(6,402	)		435,676
Accounts payable to parent or subsidiaries		—		—		223,007		(223,007	)		—
Total current liabilities		230,822		127,533		339,340		(229,409	)		468,286
Long-term liabilities
Long-term debt, less current portion		1,878,992		—		11,211		(109,822	)		1,780,381
Capital lease obligations, less current portion		132,189		75,767		43,195		—			251,151
Other long-term liabilities and deferrals		426,355		60,567		93,871		(16,766	)		564,027
Total long-term liabilities		2,437,536		136,334		148,277		(126,588	)		2,595,559
Commitments and contingencies
Equity
Cinemark USA, Inc.'s stockholder's equity:
Common stock		49,543		457,368		10,238		(467,606	)		49,543
Other stockholder's equity		1,360,059		618,985		726,830		(1,345,815	)		1,360,059
Total Cinemark USA, Inc. stockholder's equity		1,409,602		1,076,353		737,068		(1,813,421	)		1,409,602
Noncontrolling interests		—		—		11,893		—			11,893
Total equity		1,409,602		1,076,353		748,961		(1,813,421	)		1,421,495
Total liabilities and equity	$	4,077,960	$	1,340,220	$	1,236,578	$	(2,169,418	)	$	4,485,340

	Parent		Subsidiary		Subsidiary
	Company		Guarantors		Non-Guarantors		Eliminations			Consolidated

Assets
Current assets
Cash and cash equivalents	$	301,796	$	8,711	$	194,188	$	—		$	504,695
Other current assets		70,203		21,043		67,168		(34,952	)		123,462
Accounts receivable from parent or subsidiaries		—		324,697		—		(305,734	)		18,963
Total current assets		371,999		354,451		261,356		(340,686	)		647,120
Theatre properties and equipment - net		670,573		769,293		377,871		—			1,817,737
Investment in subsidiaries		1,763,463		89,214		—		(1,852,677	)		—
Other assets		1,427,050		154,648		540,294		(112,678	)		2,009,314
Total assets	$	4,233,085	$	1,367,606	$	1,179,521	$	(2,306,041	)	$	4,474,171
Liabilities and equity
Current liabilities
Current portion of long-term debt	$	6,595	$	—	$	1,389	$	—		$	7,984
Current portion of capital lease obligations		12,192		9,579		4,900		—			26,671
Accounts payable and accrued expenses		237,615		101,384		96,104		(30,324	)		404,779
Accounts payable to parent or subsidiaries		101,094		—		204,640		(305,734	)		—
Total current liabilities		357,496		110,963		307,033		(336,058	)		439,434
Long-term liabilities
Long-term debt, less current portion		1,873,393		—		9,343		(107,954	)		1,774,782
Capital lease obligations, less current portion		129,201		67,623		42,181		—			239,005
Other long-term liabilities and deferrals		401,611		59,509		85,420		(9,352	)		537,188
Total long-term liabilities		2,404,205		127,132		136,944		(117,306	)		2,550,975
Commitments and contingencies
Equity
Cinemark USA, Inc.'s stockholder's equity:
Common stock		49,543		457,368		10,238		(467,606	)		49,543
Other stockholder's equity		1,421,841		672,143		712,928		(1,385,071	)		1,421,841
Total Cinemark USA, Inc. stockholder's equity		1,471,384		1,129,511		723,166		(1,852,677	)		1,471,384
Noncontrolling interests		—		—		12,378		—			12,378
Total equity		1,471,384		1,129,511		735,544		(1,852,677	)		1,483,762
Total liabilities and equity	$	4,233,085	$	1,367,606	$	1,179,521	$	(2,306,041	)	$	4,474,171

	Parent			Subsidiary			Subsidiary
	Company			Guarantors			Non-Guarantors			Eliminations			Consolidated

Revenues	$	247,821		$	305,019		$	209,998		$	(11,643	)	$	751,195
Cost of operations
Theatre operating expenses		197,345			210,406			155,540			(11,643	)		551,648
General and administrative expenses		2,365			20,872			13,814			—			37,051
Depreciation and amortization		20,193			21,767			17,177			—			59,137
Impairment of long-lived assets		41			43			4,217			—			4,301
(Gain) loss on disposal of assets and other		5,072			(4,866	)		(152	)		—			54
Total cost of operations		225,016			248,222			190,596			(11,643	)		652,191
Operating income		22,805			56,797			19,402			—			99,004
Other income (expense)
Interest expense		(23,473	)		(1,836	)		(1,571	)		358			(26,522	)
Loss on debt amendments		(246	)		—			—			—			(246	)
Distributions from NCM		—			—			2,772			—			2,772
Equity in income of affiliates		52,156			12,299			5,851			(64,501	)		5,805
Other income		224			162			1,197			(358	)		1,225
Total other income (expense)		28,661			10,625			8,249			(64,501	)		(16,966	)
Income before income taxes		51,466			67,422			27,651			(64,501	)		82,038
Income taxes		(259	)		25,412			4,589			—			29,742
Net income		51,725			42,010			23,062			(64,501	)		52,296
Less: Net income attributable to noncontrolling interests		—			—			571			—			571
Net income attributable to Cinemark USA, Inc.	$	51,725		$	42,010		$	22,491		$	(64,501	)	$	51,725

	Parent			Subsidiary			Subsidiary
	Company			Guarantors			Non-Guarantors			Eliminations			Consolidated

Revenues	$	332,976		$	385,703		$	191,616		$	(21,242	)	$	889,053
Cost of operations
Theatre operating expenses		255,711			255,943			144,963			(21,242	)		635,375
General and administrative expenses		3,651			25,097			13,545			—			42,293
Depreciation and amortization		22,216			24,049			18,025			—			64,290
Impairment of long-lived assets		1,187			—			1,601			—			2,788
Loss on disposal of assets and other		2,462			13,978			461			—			16,901
Total cost of operations		285,227			319,067			178,595			(21,242	)		761,647
Operating income		47,749			66,636			13,021			—			127,406
Other income (expense)
Interest expense		(24,156	)		(1,703	)		(2,949	)		342			(28,466	)
Distributions from NCM		—			—			3,424			—			3,424
Interest expense - NCM		(4,913	)		—			—			—			(4,913	)
Equity in income of affiliates		68,807			2,677			6,339			(71,409	)		6,414
Other income (expense)		1,392			(62	)		(3,329	)		(342	)		(2,341	)
Total other income (expense)		41,130			912			3,485			(71,409	)		(25,882	)
Income before income taxes		88,879			67,548			16,506			(71,409	)		101,524
Income taxes		6,186			15,586			(3,270	)		—			18,502
Net income		82,693			51,962			19,776			(71,409	)		83,022
Less: Net income attributable to noncontrolling interests		—			—			329			—			329
Net income attributable to Cinemark USA, Inc.	$	82,693		$	51,962		$	19,447		$	(71,409	)	$	82,693

	Parent			Subsidiary			Subsidiary
	Company			Guarantors			Non-Guarantors			Eliminations			Consolidated

Revenues	$	517,702		$	615,975		$	421,993		$	(24,865	)	$	1,530,805
Cost of operations
Theatre operating expenses		402,576			417,589			308,086			(24,865	)		1,103,386
General and administrative expenses		6,625			41,209			26,833			—			74,667
Depreciation and amortization		39,851			42,161			34,481			—			116,493
Impairment of long-lived assets		286			71			4,217			—			4,574
(Gain) loss on disposal of assets and other		5,505			(4,682	)		65			—			888
Total cost of operations		454,843			496,348			373,682			(24,865	)		1,300,008
Operating income		62,859			119,627			48,311			—			230,797
Other income (expense)
Interest expense		(46,783	)		(3,733	)		(3,090	)		715			(52,891	)
Loss on debt amendments		(246	)		—			—			—			(246	)
Distributions from NCM		—			—			9,560			—			9,560
Equity in income of affiliates		120,245			29,754			15,327			(149,461	)		15,865
Other income		1,887			162			2,813			(715	)		4,147
Total other income (expense)		75,103			26,183			24,610			(149,461	)		(23,565	)
Income before income taxes		137,962			145,810			72,921			(149,461	)		207,232
Income taxes		6,137			43,899			24,334			—			74,370
Net income		131,825			101,911			48,587			(149,461	)		132,862
Less: Net income attributable to noncontrolling interests		—			—			1,037			—			1,037
Net income attributable to Cinemark USA, Inc.	$	131,825		$	101,911		$	47,550		$	(149,461	)	$	131,825

	Parent			Subsidiary			Subsidiary
	Company			Guarantors			Non-Guarantors			Eliminations			Consolidated

Revenues	$	615,305		$	704,124		$	384,221		$	(34,626	)	$	1,669,024
Cost of operations
Theatre operating expenses		474,489			474,473			287,459			(34,626	)		1,201,795
General and administrative expenses		6,760			49,950			27,314			—			84,024
Depreciation and amortization		43,655			48,330			36,700			—			128,685
Impairment of long-lived assets		1,201			—			2,178			—			3,379
Loss on disposal of assets and other		4,768			15,409			663			—			20,840
Total cost of operations		530,873			588,162			354,314			(34,626	)		1,438,723
Operating income		84,432			115,962			29,907			—			230,301
Other income (expense)
Interest expense		(48,384	)		(3,361	)		(4,529	)		693			(55,581	)
Loss on debt amendments		(1,484	)		—			—			—			(1,484	)
Distributions from NCM		—			—			9,782			—			9,782
Interest expense - NCM		(9,892	)		—			—			—			(9,892	)
Equity in income of affiliates		128,908			6,963			13,919			(134,740	)		15,050
Other income (expense)		2,204			(7	)		(232	)		(693	)		1,272
Total other income (expense)		71,352			3,595			18,940			(134,740	)		(40,853	)
Income before income taxes		155,784			119,557			48,847			(134,740	)		189,448
Income taxes		10,576			26,940			6,239			—			43,755
Net income		145,208			92,617			42,608			(134,740	)		145,693
Less: Net income attributable to noncontrolling interests		—			—			485			—			485
Net income attributable to Cinemark USA, Inc.	$	145,208		$	92,617		$	42,123		$	(134,740	)	$	145,208

	Parent			Subsidiary		Subsidiary
	Company			Guarantors		Non-Guarantors			Eliminations			Consolidated

Net income	$	51,725		$	42,010	$	23,062		$	(64,501	)	$	52,296
Other comprehensive loss, net of tax
Other comprehensive loss of equity method investments		(95	)		—		(95	)		95			(95	)
Foreign currency translation adjustments		(18,401	)		—		(18,401	)		18,401			(18,401	)
Total other comprehensive loss, net of tax		(18,496	)		—		(18,496	)		18,496			(18,496	)
Total comprehensive income, net of tax	$	33,229		$	42,010	$	4,566		$	(46,005	)	$	33,800
Comprehensive income attributable to noncontrolling interests		—			—		(571	)		—			(571	)
Comprehensive income attributable to Cinemark USA, Inc.	$	33,229		$	42,010	$	3,995		$	(46,005	)	$	33,229

	Parent			Subsidiary		Subsidiary
	Company			Guarantors		Non-Guarantors			Eliminations			Consolidated

Net income	$	82,693		$	51,962	$	19,776		$	(71,409	)	$	83,022
Other comprehensive loss, net of tax
Other comprehensive loss of equity method investments		(116	)		—		(116	)		116			(116	)
Foreign currency translation adjustments		(56,248	)		—		(56,248	)		56,248			(56,248	)
Total other comprehensive loss, net of tax		(56,364	)		—		(56,364	)		56,364			(56,364	)
Total comprehensive income (loss), net of tax	$	26,329		$	51,962	$	(36,588	)	$	(15,045	)	$	26,658
Comprehensive income attributable to noncontrolling interests		—			—		(329	)		—			(329	)
Comprehensive income attributable to Cinemark USA, Inc.	$	26,329		$	51,962	$	(36,917	)	$	(15,045	)	$	26,329

	Parent			Subsidiary		Subsidiary
	Company			Guarantors		Non-Guarantors			Eliminations			Consolidated

Net income	$	131,825		$	101,911	$	48,587		$	(149,461	)	$	132,862
Other comprehensive income (loss), net of tax
Other comprehensive income of equity method investments		103			—		103			(103	)		103
Foreign currency translation adjustments		(3,508	)		—		(3,508	)		3,508			(3,508	)
Total other comprehensive loss, net of tax		(3,405	)		—		(3,405	)		3,405			(3,405	)
Total comprehensive income, net of tax	$	128,420		$	101,911	$	45,182		$	(146,056	)	$	129,457
Comprehensive income attributable to noncontrolling interests		—			—		(1,037	)		—			(1,037	)
Comprehensive income attributable to Cinemark USA, Inc.	$	128,420		$	101,911	$	44,145		$	(146,056	)	$	128,420

	Parent			Subsidiary		Subsidiary
	Company			Guarantors		Non-Guarantors			Eliminations			Consolidated

Net income	$	145,208		$	92,617	$	42,608		$	(134,740	)	$	145,693
Other comprehensive income (loss), net of tax
Other comprehensive income of equity method investments		20			—		20			(20	)		20
Foreign currency translation adjustments		(56,044	)		—		(56,044	)		56,044			(56,044	)
Total other comprehensive loss, net of tax		(56,024	)		—		(56,024	)		56,024			(56,024	)
Total comprehensive income (loss), net of tax	$	89,184		$	92,617	$	(13,416	)	$	(78,716	)	$	89,669
Comprehensive income attributable to noncontrolling interests		—			—		(485	)		—			(485	)
Comprehensive income attributable to Cinemark USA, Inc.	$	89,184		$	92,617	$	(13,901	)	$	(78,716	)	$	89,184

	Parent			Subsidiary			Subsidiary
	Company			Guarantors			Non-Guarantors			Eliminations			Consolidated

Operating activities
Net income	$	131,825		$	101,911		$	48,587		$	(149,461	)	$	132,862
Adjustments to reconcile net income to cash provided by (used for) operating activities		(62,144	)		13,264			36,647			149,461			137,228
Changes in assets and liabilities		(83,338	)		38,444			10,170			—			(34,724	)
Net cash provided by (used for) operating activities		(13,657	)		153,619			95,404			—			235,366
Investing activities
Additions to theatre properties and equipment		(62,198	)		(92,383	)		(28,219	)		—			(182,800	)
Acquisition of theatres in the U.S. and international markets, net of cash acquired		(12,500	)		—			(28,329	)		—			(40,829	)
Proceeds from sale of theatre properties and equipment and other		2,143			12,255			123			—			14,521
Dividends received from subsidiaries		127,300			6			—			(127,306	)		—
Investment in joint ventures and other		—			—			(466	)		—			(466	)
Net cash provided by (used for) investing activities		54,745			(80,122	)		(56,891	)		(127,306	)		(209,574	)
Financing activities
Dividends paid to parent		(67,250	)		(127,000	)		(306	)		127,306			(67,250	)
Repayments of long-term debt		(1,427	)		—			—			—			(1,427	)
Payments on capital leases		(3,628	)		(4,632	)		(1,883	)		—			(10,143	)
Other		(784	)		(2,921	)		(294	)		—			(3,999	)
Net cash used for financing activities		(73,089	)		(134,553	)		(2,483	)		127,306			(82,819	)
Effect of exchange rate changes on cash and cash equivalents		—			—			(75	)		—			(75	)
Increase (decrease) in cash and cash equivalents		(32,001	)		(61,056	)		35,955			—			(57,102	)
Cash and cash equivalents:
Beginning of year		146,855			281,023			133,260			—			561,138
End of year	$	114,854		$	219,967		$	169,215		$	—		$	504,036

	Parent			Subsidiary			Subsidiary
	Company			Guarantors			Non-Guarantors			Eliminations			Consolidated

Operating activities
Net income	$	145,208		$	92,617		$	42,608		$	(134,740	)	$	145,693
Adjustments to reconcile net income to cash provided by (used for) operating activities		(73,458	)		62,445			38,412			134,740			162,139
Changes in assets and liabilities		230,402			(220,516	)		(38,073	)		—			(28,187	)
Net cash provided by (used for) operating activities		302,152			(65,454	)		42,947			—			279,645
Investing activities
Additions to theatre properties and equipment		(44,970	)		(79,756	)		(37,863	)		—			(162,589	)
Acquisition of theatres in international markets, net of cash acquired		—			—			(11,508	)		—			(11,508	)
Proceeds from sale of theatre properties and equipment and other		1,244			485			406			—			2,135
Proceeds from intercompany note repayment		1,867			—			—			(1,867	)		—
Investment in joint ventures and other		—			(19,896	)		429			—			(19,467	)
Net cash used for investing activities		(41,859	)		(99,167	)		(48,536	)		(1,867	)		(191,429	)
Financing activities
Dividends paid to parent		(74,350	)		—			—			—			(74,350	)
Repayments of long-term debt		(3,298	)		—			—			—			(3,298	)
Payment of debt issue costs		(5,103	)		—			—			—			(5,103	)
Repayment of intercompany note		—			—			(1,867	)		1,867			—
Payments on capital leases		(5,632	)		(4,386	)		(2,359	)		—			(12,377	)
Other		(704	)		(2,905	)		—			—			(3,609	)
Net cash used for financing activities		(89,087	)		(7,291	)		(4,226	)		1,867			(98,737	)
Effect of exchange rate changes on cash and cash equivalents		—			—			(7,199	)		—			(7,199	)
Increase (decrease) in cash and cash equivalents		171,206			(171,912	)		(17,014	)		—			(17,720	)
Cash and cash equivalents:
Beginning of year		130,590			180,623			211,202			—			522,415
End of year	$	301,796		$	8,711		$	194,188		$	—		$	504,695

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis should be read in conjunction with our condensed consolidated financial statements and related notes and schedules included elsewhere in this report.

We are a leader in the motion picture exhibition industry, with theatres in the U.S., Brazil, Argentina, Chile, Colombia, Ecuador, Peru, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, Curacao and Paraguay. As of June 30, 2018, we managed our business under two reportable operating segments – U.S. markets and international markets. See Note 14 to our condensed consolidated financial statements.

We generate revenues primarily from filmed entertainment box office receipts and concession sales with additional revenues from screen advertising sales, transactional fees and other revenue streams, such as vendor marketing promotions and meeting rentals located in some of our theatres. We also offer alternative entertainment, such as live and pre-recorded sports programs, concert events, the Metropolitan Opera, in-theatre gaming and other special events in our theatres through AC JV, LLC. NCM provides our domestic theatres with various forms of in theatre advertising. Our Flix Media subsidiaries have also allowed us to expand our screen advertising and alternative content within our international circuit and to other international exhibitors.

Films leading the box office during the six months ended June 30, 2018 included the carryover of Jumanji: Welcome to the Jungle, The Greatest Showman and Star Wars: The Last Jedi and new releases such as Black Panther, Avengers: Infinity War, Incredibles 2, Deadpool 2, Jurassic World: Fallen Kingdom, Solo: A Star Wars Story, A Quiet Place, Ready Player One, Peter Rabbit, Ocean’s 8 and other films. Films scheduled for release during the remainder of 2018 include well-known franchise films such as Ralph Breaks the Internet, Dr. Seuss’ The Grinch, Fantastic Beasts: The Crimes of Grindelwald, Ant-Man and the Wasp, Mission Impossible – Fallout and Hotel Transylvania 3: Summer Vacation and original titles including AquaMan, Christopher Robin and Mary Poppins, among other films.

Film rental costs are variable in nature and fluctuate with our admissions revenues. Film rental costs as a percentage of revenues are generally higher for periods in which more blockbuster films are released. Advertising costs, which are expensed as incurred, are primarily related to campaigns for new and renovated theatres, loyalty and membership programs and brand advertising that vary depending on the timing of such campaigns.

Concession supplies expense is variable in nature and fluctuates with our concession revenues. We negotiate prices for concession supplies directly with concession vendors and manufacturers to obtain volume rates.

Although salaries and wages include a fixed cost component (i.e. the minimum staffing costs to operate a theatre facility during non-peak periods), salaries and wages move in relation to revenues as theatre staffing is adjusted to respond to changes in attendance. In some international locations, staffing levels are also subject to local regulations.

Facility lease expense is primarily a fixed cost at the theatre level as most of our facility leases require a fixed monthly minimum rent payment. Certain leases are subject to percentage rent only, while others are subject to percentage rent in addition to their fixed monthly rent if a target annual performance level is achieved. Facility lease expense as a percentage of revenues is also affected by the number of theatres under operating leases, the number of theatres under capital leases and the number of fee-owned theatres.

Utilities and other costs include both fixed and variable costs and primarily consist of utilities, expenses for projection and sound equipment maintenance and monitoring, property taxes, janitorial costs, repairs, maintenance and security services.

General and administrative expenses are primarily fixed in nature and consist of the costs to support the overall management of the Company, including salaries and wages, incentive compensation and benefit costs for our corporate office personnel, facility expenses for our corporate offices, consulting fees, legal fees, audit fees, supplies and other costs that are not specifically associated with the operations of our theatres.

On July 5, 2018 we acquired 10,738,740 common units of NCM from AMC for $78.4 million in cash, or approximately $7.30 per common unit. As a result of the acquisition of these shares, our ownership of NCM increased from approximately 18% to 25%. The amount paid for the additional common units will be recorded as an increase in our investment in NCM. See Note 6 to our condensed consolidated financial statements for further discussion of the accounting for our investment in NCM.

We adopted ASC Topic 606 effective January 1, 2018, therefore, our revenue recognition policy has been modified as discussed in Note 3 to our condensed consolidated financial statements.

The following table sets forth, for the periods indicated, certain operating data and the percentage of revenues represented by certain items reflected in our condensed consolidated statements of income.

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2018			2017			2018			2017
Operating data (in millions):
Revenues
Admissions	$	508.9		$	449.9		$	961.5		$	926.4
Concession		305.3			262.3			567.1			530.5
Other		74.8			39.0			140.4			73.9
Total revenues	$	889.0		$	751.2		$	1,669.0		$	1,530.8
Cost of operations
Film rentals and advertising		287.1			246.6			528.1			499.4
Concession supplies		51.1			41.8			91.9			83.9
Salaries and wages		100.4			89.8			193.5			174.0
Facility lease expense		81.2			82.3			163.3			166.6
Utilities and other		115.6			91.0			225.0			179.4
General and administrative expenses		42.3			37.1			84.0			74.7
Depreciation and amortization		64.3			59.2			128.7			116.5
Impairment of long-lived assets		2.8			4.3			3.4			4.6
Loss on disposal of assets and other		16.9			0.1			20.8			0.9
Total cost of operations		761.7			652.2			1,438.7			1,300.0
Operating income	$	127.3		$	99.0		$	230.3		$	230.8

Operating data as a percentage of total revenues:
Revenues
Admissions		57.2	%		59.9	%		57.6	%		60.5	%
Concession		34.3	%		34.9	%		34.0	%		34.7	%
Other		8.5	%		5.2	%		8.4	%		4.8	%
Total revenues		100.0	%		100.0	%		100.0	%		100.0	%
Cost of operations ⁽¹⁾
Film rentals and advertising		56.4	%		54.8	%		54.9	%		53.9	%
Concession supplies		16.7	%		15.9	%		16.2	%		15.8	%
Salaries and wages		11.3	%		12.0	%		11.6	%		11.4	%
Facility lease expense		9.1	%		11.0	%		9.8	%		10.9	%
Utilities and other		13.0	%		12.1	%		13.5	%		11.7	%
General and administrative expenses		4.8	%		4.9	%		5.0	%		4.9	%
Depreciation and amortization		7.2	%		7.9	%		7.7	%		7.6	%
Impairment of long-lived assets		0.3	%		0.6	%		0.2	%		0.3	%
Loss on disposal of assets and other		1.9	%		—	%		1.2	%		0.1	%
Total cost of operations		85.7	%		86.8	%		86.2	%		84.9	%
Operating income		14.3	%		13.2	%		13.8	%		15.1	%

Revenues. Total revenues increased $137.8 million to $889.0 million for the three months ended June 30, 2018 (“second quarter of 2018”) from $751.2 million for the three months ended June 30, 2017 (“second quarter of 2017”), representing an 18.3% increase. The table below, presented by reportable operating segment, summarizes our revenue performance and certain key performance indicators for the three months ended June 30, 2018 and 2017.

	U.S. Operating Segment							International Operating Segment												Consolidated
															Constant Currency ⁽³⁾
	2018		2017		% Change			2018		2017		% Change			2018		% Change			2018		2017		% Change
Admissions revenues ⁽¹⁾	$	408.9	$	335.0		22.1	%	$	100.0	$	114.9		(13.0	)%	$	111.7		(2.8	)%	$	508.9	$	449.9		13.1	%
Concession revenues ⁽¹⁾	$	249.6	$	197.3		26.5	%	$	55.7	$	65.0		(14.3	)%	$	61.5		(5.4	)%	$	305.3	$	262.3		16.4	%
Other revenues ⁽¹⁾⁽²⁾	$	50.5	$	18.9		167.2	%	$	24.3	$	20.1		20.9	%	$	27.7		37.8	%	$	74.8	$	39.0		91.8	%
Total revenues ⁽¹⁾⁽²⁾	$	709.0	$	551.2		28.6	%	$	180.0	$	200.0		(10.0	)%	$	200.9		0.4	%	$	889.0	$	751.2		18.3	%
Attendance ⁽¹⁾		50.6		43.0		17.7	%		25.8		26.4		(2.3	)%							76.4		69.4		10.1	%
Average ticket price ⁽¹⁾	$	8.08	$	7.79		3.7	%	$	3.88	$	4.35		(10.8	)%	$	4.33		(0.5	)%	$	6.66	$	6.48		2.8	%
Concession revenues per patron ⁽¹⁾	$	4.93	$	4.59		7.4	%	$	2.16	$	2.46		(12.2	)%	$	2.38		(3.3	)%	$	4.00	$	3.78		5.8	%

Cost of Operations. The table below summarizes our theatre operating costs (in millions) by reportable operating segment for the three months ended June 30, 2018 and 2017.

	U.S. Operating Segment				International Operating Segment						Consolidated
	2018		2017		2018		2017		Constant Currency 2018 ⁽¹⁾		2018		2017
Film rentals and advertising	$	238.7	$	190.4	$	48.4	$	56.2	$	54.3	$	287.1	$	246.6
Concession supplies	$	38.4	$	27.8	$	12.7	$	14.0	$	14.0		51.1		41.8
Salaries and wages	$	79.4	$	66.7	$	21.0	$	23.1	$	24.0		100.4		89.8
Facility lease expense	$	61.0	$	59.9	$	20.2	$	22.4	$	22.1		81.2		82.3
Utilities and other	$	83.7	$	61.1	$	31.9	$	29.9	$	36.0		115.6		91.0

Salaries and wages increased to $79.4 million for the second quarter of 2018 from $66.7 million for the second quarter of 2017 primarily due to increased staffing levels to support the growth in attendance and expanded concession offerings, staffing at new and recently remodeled theatres, as well as increases in minimum and other wage rates. Facility lease expense increased to $61.0 million for the second quarter of 2018 from $59.9 million for the second quarter of 2017 primarily due to higher percentage rent due to the increase in revenues. Utilities and other costs increased to $83.7 million for the second quarter of 2018 from $61.1 million for the second quarter of 2017 primarily due to the presentation of transactional fees on a gross basis versus net basis due to the adoption of ASC Topic 606 (see Note 3 to our condensed consolidated financial statements).

Salaries and wages decreased to $21.0 million (increased to $24.0 million in constant currency) for the second quarter of 2018 compared to $23.1 million for the second quarter of 2017. The as reported decrease was due to the impact of changes in foreign currency exchange rates in certain countries in which we operate, partially offset by increased local currency wages that were primarily driven by inflation, new theatres and limited flexibility in scheduling staff caused by shifting government regulations. Facility lease expense decreased to $20.2 million ($22.1 million in constant currency) for the second quarter of 2018 compared to $22.4 million for the second quarter of 2017. The as reported decrease was due to lower percentage rent due to the decline in revenues. Utilities and other costs increased to $31.9 million ($36.0 million in constant currency) for the second quarter of 2018 compared to $29.9 million for the second quarter of 2017. The as reported increase was primarily due to the presentation of transactional fees on a gross basis versus net basis due to the adoption of ASC Topic 606 (see Note 3 to our condensed consolidated financial statements).

General and Administrative Expenses. General and administrative expenses increased to $42.3 million for the second quarter of 2018 from $37.1 million for the second quarter of 2017. The increase was primarily due to higher salaries, insurance costs, benefits costs and professional fees.

Depreciation and Amortization. Depreciation and amortization expense increased to $64.3 million during the second quarter of 2018 compared to $59.2 million during the second quarter of 2017. The increase was primarily due to theatre remodels and new theatres.

Impairment of Long-Lived Assets. We recorded asset impairment charges on assets held and used of $2.8 million during the second quarter of 2018 compared to $4.3 million during the second quarter of 2017. The long-lived asset impairment charges recorded during each of the periods presented were specific to theatres that were directly and individually impacted by increased competition, adverse changes in market demographics or adverse changes in the development or the conditions of the areas surrounding the theatre. Impairment charges for the second quarter of 2018 impacted five of our twenty-seven reporting units. See Note 10 to our condensed consolidated financial statements.

Loss on Disposal of Assets and Other. We recorded a loss on disposal of assets and other of $16.9 million during the second quarter of 2018 compared to $0.1 million during the second quarter of 2017. Activity for the second quarter of 2018 was primarily due to the retirement of assets related to theatre remodels and the accrual of a reserve for outstanding litigation (see Note 16 to the condensed consolidated financial statements). Activity for the second quarter of 2017 was primarily due to the retirement of assets related to theatre remodels, offset by a gain on a landlord buyout of a theatre lease.

Interest Expense. Interest costs incurred, including amortization of debt issue costs, were $28.5 million during the second quarter of 2018 compared to $26.5 million during the second quarter of 2017. The increase was primarily due to an increase in the variable rate at which our term loan accrues interest.

Distributions from NCM. We recorded distributions from NCM of $3.4 million during the second quarter of 2018 compared to $2.8 million recorded during the second quarter of 2017, which were in excess of the carrying value of our Tranche 1 investment. See Note 6 to our condensed consolidated financial statements.

Interest expense – NCM. We recorded non-cash interest expense of $4.9 million for the second quarter of 2018 related to the significant financing component associated with certain of our agreements with NCM. See Note 3 to our condensed consolidated financial statements for further discussion.

Equity in Income of Affiliates. We recorded equity in income of affiliates of $6.4 million during the second quarter of 2018 compared to $5.8 million during the second quarter of 2017. See Notes 6 and 7 to our condensed consolidated financial statements for information about our equity investments.

Income Taxes. Income tax expense of $18.5 million was recorded for the second quarter of 2018 compared to $29.7 million recorded for the second quarter of 2017. The effective tax rate was approximately 18.2% for the second quarter of 2018 compared to 36.3% for the second quarter of 2017. The effective tax rate in 2018 benefited from a lower U.S. federal tax rate. On December 22, 2017, the U.S. government enacted comprehensive tax legislation, the Tax Cuts and Jobs Act (the "Tax Act"). The Tax Act made changes to the U.S. tax code, which included (1) reduced U.S. corporate tax rate from 35 percent to 21 percent, (2) generally eliminated U.S. federal income taxes on dividends from foreign subsidiaries, and (3) a one-time transition tax on certain undistributed earnings of foreign subsidiaries. Additionally, the Company recorded a benefit to tax expense of $7.1 million for the second quarter of 2018 related to the settlement of audits in the non-U.S. tax jurisdiction of Chile.

As of June 30, 2018, the amounts recorded for the Tax Act remain provisional for the transition tax, the re-measurement of deferred taxes, and our reassessment of valuation allowances. These estimates may be impacted by further analysis due to future clarification and guidance regarding earnings and profits computations, state tax conformity to federal tax changes, and potential tax planning options under consideration.

Income tax provisions for interim (quarterly) periods are based on estimated annual income tax rates and are adjusted for the effects of significant, infrequent or unusual items (i.e. discrete items) occurring during the interim period. As a result, the interim rate may vary significantly from the normalized annual rate.

Revenues. Total revenues increased $138.2 million to $1,669.0 million for the six months ended June 30, 2018 (“2018 period”) from $1,530.8 million for the six months ended June 30, 2017 (“2017 period”), representing a 9.0% increase. The table below, presented by reportable operating segment, summarizes our revenue performance and certain key performance indicators for the six months ended June 30, 2018 and 2017.

	U.S. Operating Segment							International Operating Segment												Consolidated
															Constant Currency ⁽³⁾
	2018		2017		% Change			2018		2017		% Change			2018		% Change			2018		2017		% Change
Admissions revenues ⁽¹⁾	$	758.2	$	691.2		9.7	%	$	203.3	$	235.2		(13.6	)%	$	219.4		(6.7	)%	$	961.5	$	926.4		3.8	%
Concession revenues ⁽¹⁾	$	453.4	$	400.7		13.2	%	$	113.7	$	129.8		(12.4	)%	$	121.6		(6.3	)%	$	567.1	$	530.5		6.9	%
Other revenues ⁽¹⁾⁽²⁾	$	93.8	$	36.9		154.2	%	$	46.6	$	37.0		25.9	%	$	51.5		39.2	%	$	140.4	$	73.9		90.0	%
Total revenues ⁽¹⁾⁽²⁾	$	1,305.4	$	1,128.8		15.6	%	$	363.6	$	402.0		(9.6	)%	$	392.5		(2.4	)%	$	1,669.0	$	1,530.8		9.0	%
Attendance ⁽¹⁾		95.2		89.5		6.4	%		49.7		54.2		(8.3	)%							144.9		143.7		0.8	%
Average ticket price ⁽¹⁾	$	7.96	$	7.72		3.1	%	$	4.09	$	4.34		(5.8	)%	$	4.41		1.6	%	$	6.64	$	6.45		2.9	%
Concession revenues per patron ⁽¹⁾	$	4.76	$	4.48		6.2	%	$	2.29	$	2.39		(4.2	)%	$	2.45		2.5	%	$	3.91	$	3.69		6.0	%

Cost of Operations. The table below summarizes our theatre operating costs (in millions) by reportable operating segment for the six months ended June 30, 2018 and 2017.

	U.S. Operating Segment				International Operating Segment						Consolidated
	2018		2017		2018		2017		Constant Currency 2018 ⁽¹⁾		2018		2017
Film rentals and advertising	$	431.6	$	386.8	$	96.5	$	112.6	$	104.5	$	528.1	$	499.4
Concession supplies	$	66.9	$	55.9	$	25.0	$	28.0	$	26.8	$	91.9	$	83.9
Salaries and wages	$	151.1	$	129.9	$	42.4	$	44.1	$	46.7	$	193.5	$	174.0
Facility lease expense	$	122.0	$	121.3	$	41.3	$	45.3	$	43.8	$	163.3	$	166.6
Utilities and other	$	162.7	$	121.1	$	62.3	$	58.3	$	68.1	$	225.0	$	179.4

Salaries and wages increased to $151.1 million for the 2018 period from $129.9 million for the 2017 period primarily due to increased staffing levels to support the increased attendance and expanded concession offerings, staffing at new and recently remodeled theatres, increases in minimum and other wage rates. Facility lease expense increased to $122.0 million for the 2018 period from $121.3 million for the 2017 period primarily due to increased percentage rent due to the increase in revenues. Utilities and other costs increased to $162.7 million for the 2018 period from $121.1 million for the 2017 period primarily due to the presentation of transactional fees on a gross basis versus net basis due to the adoption of ASC Topic 606 (see Note 3 to our condensed consolidated financial statements).

Salaries and wages decreased to $42.4 million (increased to $46.7 million in constant currency) for the 2018 period compared to $44.1 million for the 2017 period. The as reported decrease was due to the impact of changes in foreign currency exchange rates in certain countries in which we operate, partially offset by increased local currency wages that were primarily driven by inflation, new theatres and limited flexibility in scheduling staff caused by shifting government regulations. Facility lease expense decreased to $41.3 million ($43.8 million in constant currency) for the 2018 period compared to $45.3 million for the 2017 period. The as reported decrease was due to lower percentage rent due to the decline in revenues. Utilities and other costs increased to $62.3 million ($68.1 million in constant currency) for the 2018 period compared to $58.3 million for the 2017 period. The as reported increase was primarily due to the presentation of transactional fees on a gross basis versus net basis due to the adoption of ASC Topic 606 (see Note 3 to our condensed consolidated financial statements).

General and Administrative Expenses. General and administrative expenses increased to $84.0 million for the 2018 period from $74.7 million for the 2017 period. The increase was primarily due to higher salaries, insurance costs, benefits costs and professional fees.

Depreciation and Amortization. Depreciation and amortization expense increased to $128.7 million during the 2018 period compared to $116.5 million during the 2017 period. The increase was primarily due to theatre remodels and new theatres.

Impairment of Long-Lived Assets. We recorded asset impairment charges on assets held and used of $3.4 million during the 2018 period compared to $4.6 million during the 2017 period. The long-lived asset impairment charges recorded during each of the periods presented were specific to theatres that were directly and individually impacted by increased competition, adverse changes in market demographics or adverse changes in the development or the conditions of the areas surrounding the theatre. Impairment charges for the 2018 period impacted six of our twenty-seven reporting units. See Note 10 to our condensed consolidated financial statements.

Loss on Disposal of Assets and Other. We recorded a loss on disposal of assets and other of $20.8 million during the 2018 period compared to $0.9 million during the 2017 period. Activity for the 2018 period was primarily due to the retirement of assets related to theatre remodels and the accrual of a reserve for outstanding litigation (see Note 16 to the condensed consolidated financial statements). Activity for the 2017 period was primarily due to the retirement of assets related to theatre remodels, partially offset by gains related to the sale of excess land parcels and a gain on a landlord buyout of a theatre lease.

Interest Expense. Interest costs incurred, including amortization of debt issue costs, were $55.6 million during the 2018 period compared to $52.9 million during the 2017 period. The increase was primarily due to an increase in the variable rate at which our term loan accrues interest.

Loss on Debt Amendments. We recorded a loss on debt amendments of $1.5 million for the 2018 period compared to $0.2 million for the 2017 period related to amendments to our senior secured credit facility. See Note 4 to our condensed consolidated financial statements for further discussion.

Distributions from NCM. We recorded distributions from NCM of $9.8 million during the 2018 period compared to $9.6 million recorded during the 2017 period, which were in excess of the carrying value of our Tranche 1 investment. See Note 6 to our condensed consolidated financial statements.

Interest expense – NCM. We recorded non-cash interest expense of $9.9 million for the 2018 period related to the significant financing component associated with certain of our agreements with NCM. See Note 3 to our condensed consolidated financial statements for further discussion.

Equity in Income of Affiliates. We recorded equity in income of affiliates of $15.1 million during the 2018 period compared to $15.9 million during the 2017 period. See Notes 6 and 7 to our condensed consolidated financial statements for information about our equity investments.

Income Taxes. Income tax expense of $43.8 million was recorded for the 2018 period compared to $74.4 million recorded for the 2017 period. The effective tax rate was approximately 23.1% for the 2018 period compared to 35.9% for the 2017 period. The effective tax rate in 2018 benefited from a lower U.S. federal tax rate. On December 22, 2017, the U.S. government enacted comprehensive tax legislation, the Tax Cuts and Jobs Act (the "Tax Act"). The Tax Act made changes to the U.S. tax code, which included (1) reduced U.S. corporate tax rate from 35 percent to 21 percent, (2) generally eliminated U.S. federal income taxes on dividends from foreign subsidiaries, and (3) a one-time transition tax on certain undistributed earnings of foreign subsidiaries. Additionally, the Company recorded a benefit to tax expense of $7.1 million for the 2018 period related to the settlement of audits in the non-U.S. tax jurisdiction of Chile.

We primarily collect our revenues in cash, mainly through box office receipts and the sale of concessions. In addition, nearly all of our theatres provide the patron a choice of using a credit card, debit card or advanced-sale type certificates such as a gift card, in place of cash. Because our revenues are received in cash prior to the payment of related expenses, we have an operating “float” and historically have not required traditional working capital financing. Cash provided by operating activities was $279.6 million for the six months ended June 30, 2018 compared to $235.4 million for the six months ended June 30, 2017. The increase in cash provided by operating activities was primarily due to the increase in net income and the timing of payments to suppliers.

Our investing activities have been principally related to the development, remodel and acquisition of theatres. New theatre openings and acquisitions historically have been financed with internally generated cash and by debt financing, including borrowings under our senior secured credit facility. Cash used for investing activities was $191.4 million for the six months ended June 30, 2018 compared to $209.6 million for the six months ended June 30, 2017. The decrease was primarily due to a decrease in capital expenditures and a decrease in cash paid related to the acquisition of theatres.

Capital expenditures for the six months ended June 30, 2018 and 2017 were as follows (in millions):

Capital expenditures for existing properties in the table above includes the costs of remodeling certain of our existing theatres to include Luxury Loungers and expanded concession offerings. During the six months ended June 30, 2018 and 2017, we had an average of 78 and 132 of our domestic screens, respectively, temporarily closed for such remodels.

Our U.S. theatre circuit consisted of 339 theatres with 4,566 screens at June 30, 2018. During the six months ended June 30, 2018, we built one new theatre and twelve screens and closed one theatre with seven screens. At June 30, 2018, we had signed commitments to open three new theatres and 30 screens in domestic markets during the remainder of 2018 and open nine new theatres with 95 screens subsequent to 2018. We estimate the remaining capital expenditures for the development of these 125 domestic screens will be approximately $99 million.

Our international theatre circuit consisted of 200 theatres with 1,432 screens at June 30, 2018. During the six months ended June 30, 2018, we built three theatres and fifteen screens and acquired three theatres and nineteen screens. At June 30, 2018, we had signed commitments to open five new theatres and 29 screens in international markets during the remainder of 2018 and open seven new theatres and 51 screens subsequent to 2018. We estimate the remaining capital expenditures for the development of these 80 international screens will be approximately $46 million.

Actual expenditures for continued theatre development, remodels and acquisitions are subject to change based upon the availability of attractive opportunities. We plan to fund capital expenditures for our continued development with cash flow from operations, borrowings under our senior secured credit facility, and proceeds from debt issuances, sale leaseback transactions and/or sales of excess real estate.

Cash used for financing activities was $98.7 million for the six months ended June 30, 2018 compared to $82.8 million for the six months ended June 30, 2017. The increase was primarily due to the payment of debt issuance costs associated with the amendment of our senior secured credit facility (see Note 4 to our condensed consolidated financial statements) and the increase in the dividends paid to Cinemark Holdings, Inc.

We may from time to time, subject to compliance with our debt instruments, purchase our debt securities on the open market depending upon the availability and prices of such securities. Long-term debt consisted of the following as of June 30, 2018 (in millions):

As of June 30, 2018, Cinemark USA, Inc. had $100.0 million in available borrowing capacity on our revolving credit line.

In March 2018, we amended our senior secured credit facility, which extended the maturity of the term loan to March 2025. Included below is an updated summary of long-term debt obligations and related estimated scheduled interest payment obligations as of June 30, 2018, reflecting the amended agreement.

There have been no other material changes in our contractual obligations previously disclosed in “Liquidity and Capital Resources” in our Annual Report on Form 10-K for the year ended December 31, 2017 filed March 2, 2018.

Other than operating leases and purchase commitments disclosed in our Annual Report on Form 10-K for the year ended December 31, 2017 filed March 2, 2018, we do not have any off-balance sheet arrangements.

Cinemark USA, Inc. has a senior secured credit facility that includes a $700.0 million term loan, with a maturity date of March 2025, and a $100.0 million revolving credit line, with a maturity date of December 2022 (collectively referred to as the “Credit Agreement”).

On March 29, 2018, Cinemark USA, Inc., amended its senior secured credit facility to extend the maturity of the term loan to March 29, 2025, reduce the rate at which the term loan bears interest by 0.25% and to reduce the amount of real property required to be mortgaged to secure the loans. Under the amended facility, quarterly principal payments of $1.6 million are due on the term loan through December 31, 2024, with a final principal payment of $613.4 million due on March 29, 2025.

Interest on the term loan accrues at Cinemark USA, Inc.’s option at: (A) the base rate equal to the greater of (1) the US “Prime Rate” as quoted in The Wall Street Journal or if no such rate is quoted therein, in a Federal Reserve Board statistical release, (2) the federal funds effective rate plus 0.50%, and (3) a one-month Eurodollar-based rate plus 1.0%, plus, in each case, a margin of 0.75% per annum, or (B) a Eurodollar-based rate for a period of 1, 2, 3, 6, 9 or 12 months plus a margin of 1.75% per annum. Interest on the revolving credit line accrues, at our option, at: (A) a base rate equal to the greater of (1) the US “Prime Rate” as quoted in The Wall Street Journal or if no such rate is quoted therein, in a Federal Reserve Board statistical release, (2) the federal funds effective rate plus 0.50%, and (3) a one-month Eurodollar-based rate plus 1.0%, plus, in each case, a margin that ranges from 0.50% to 1.25% per annum, or (B) a Eurodollar-based rate for a period of 1, 2, 3, 6, 9 or 12 months plus a margin that ranges from 1.50% to 2.25% per annum. The margin of the revolving credit line is determined by the consolidated net senior secured leverage ratio as defined in the Credit Agreement.

Cinemark USA, Inc.’s obligations under the Credit Agreement are guaranteed by Cinemark Holdings, Inc. and certain of Cinemark USA, Inc.’s domestic subsidiaries and are secured by mortgages on certain fee and leasehold properties and security interests in substantially all of Cinemark USA, Inc.’s and the guarantors’ personal property, including, without limitation, pledges of all of Cinemark USA, Inc.’s capital stock, all of the capital stock of certain of Cinemark USA, Inc.’s domestic subsidiaries and 65% of the voting stock of certain of its foreign subsidiaries.

The Credit Agreement contains usual and customary negative covenants for agreements of this type, including, but not limited to, restrictions on Cinemark USA, Inc.’s ability, and in certain instances, its subsidiaries’ and our ability, to consolidate or merge or liquidate, wind up or dissolve; substantially change the nature of its business; sell, transfer or dispose of assets; create or incur indebtedness; create liens; pay dividends or repurchase stock; and make capital expenditures and investments. If Cinemark USA, Inc. has borrowings outstanding on the revolving credit line, it is required to satisfy a consolidated net senior secured leverage ratio covenant as defined in the Credit Agreement.

The dividend restriction contained in the Credit Agreement prevents the Company and any of its subsidiaries from paying a dividend or otherwise distributing cash to its stockholders unless (1) the Company is not in default, and the distribution would not cause Cinemark USA, Inc. to be in default, under the Credit Agreement; and (2) the aggregate amount of certain dividends, distributions, investments, redemptions and capital expenditures made since December 18, 2012, including dividends declared by the board of directors, is less than the sum of (a) the aggregate amount of cash and cash equivalents received by Cinemark Holdings, Inc. or Cinemark USA, Inc. as common equity since December 18, 2012, (b) Cinemark USA, Inc.’s consolidated EBITDA minus 1.75 times its consolidated interest expense, each as defined in the Credit Agreement, and (c) certain other defined amounts. As of June 30, 2018, Cinemark USA, Inc. could have distributed up to approximately $2,790.4 million to its parent company and sole stockholder, Cinemark Holdings, Inc., under the terms of the Credit Agreement, subject to its available cash and other borrowing restrictions outlined in the agreement.

At June 30, 2018, there was $656.2 million outstanding under the term loan and no borrowings outstanding under the revolving credit line. Cinemark USA, Inc. had $100.0 million in available borrowing capacity on the revolving credit line. The average interest rate on outstanding term loan borrowings under the Credit Agreement at June 30, 2018 was approximately 3.9 % per annum.

On December 18, 2012, Cinemark USA, Inc. issued $400.0 million aggregate principal amount of 5.125% Senior Notes due 2022, at par value (the “5.125% Senior Notes”). Interest on the 5.125% Senior Notes is payable on June 15 and December 15 of each year. The 5.125% Senior Notes mature on December 15, 2022.

The indenture to the 5.125% Senior Notes contains covenants including limitations on the amount of dividends that could be paid by Cinemark USA, Inc. As of June 30, 2018, Cinemark USA, Inc. could have distributed up to approximately $2,442.4 million to its parent company and sole stockholder, Cinemark Holdings, Inc., under the terms of the indenture to the 5.125% Senior Notes, subject to its available cash and other borrowing restrictions outlined in the indenture. The indenture allows Cinemark USA, Inc. to incur additional indebtedness if it satisfies the coverage ratio specified in the indenture, after giving effect to the incurrence of the additional indebtedness, and in certain other circumstances. The required minimum coverage ratio is 2 to 1 and our actual ratio as of June 30, 2018 was approximately 6.3 to 1.

On May 24, 2013, Cinemark USA, Inc. issued $530.0 million aggregate principal amount of 4.875% Senior Notes due 2023, at par value (the “4.875% Senior Notes”). On March 21, 2016, Cinemark USA, Inc. issued an additional $225.0 million aggregate

principal amount of the 4.875% Senior Notes at 99.0% of the principal amount plus accrued and unpaid interest from December 1, 2015. Proceeds, after payment of fees, were used to finance the redemption of Cinemark, USA, Inc.’s $200.0 million 7.375% Senior Subordinated Notes. These additional notes have identical terms, other than the issue date, the issue price and the first interest payment date, and constitute part of the same series as the Company’s existing 4.875% Senior Notes. Interest on the 4.875% Senior Notes is payable on June 1 and December 1 of each year. The 4.875% Senior Notes mature on June 1, 2023.

The indenture to the 4.875% Senior Notes contains covenants that include limitations on the amount of dividends that Cinemark USA, Inc. can pay. As of June 30, 2018, Cinemark USA, Inc. could have distributed up to approximately $2,437.1 million to its parent company and sole stockholder, Cinemark Holdings, Inc., under the terms of the indenture to the 4.875% Senior Notes, subject to its available cash and other borrowing restrictions outlined in the indenture. The indenture allows Cinemark USA, Inc. to incur additional indebtedness if it satisfies the coverage ratio specified in the indenture, after giving effect to the incurrence of the additional indebtedness, and in certain other circumstances. The required minimum coverage ratio is 2 to 1 and our actual ratio as of June 30, 2018 was approximately 6.3 to 1.

As of June 30, 2018, we believe we were in full compliance with all agreements, including all related covenants, governing our outstanding debt.

Our revenues have historically been seasonal, coinciding with the timing of releases of motion pictures by the major distributors. Generally, the most successful motion pictures have been released during summer months in the U.S., extending from May to July, and during the holiday season, extending from November through year-end. The timing of releases, however, has become less pronounced as distributors have begun releasing content more evenly throughout the year. In our Latin American markets, while Hollywood content has similar release dates as in the U.S., the local holidays and seasons can vary. The unexpected emergence of a hit film during other periods can impact this seasonality trend. The timing and quality of film releases can have a significant impact on our results of operations, and the results of one period are not necessarily indicative of results for the following period or for the same period in the following year.

We have exposure to financial market risks, including changes in interest rates, foreign currency exchange rates and other relevant market prices.

We are currently party to a variable rate debt facility. An increase or decrease in interest rates would affect our interest expense relating to our variable rate debt. At June 30, 2018, we had an aggregate of approximately $656.2 million of variable rate debt outstanding. Based on the interest rates in effect on the variable rate debt outstanding at June 30, 2018, a 100 basis point increase in market interest rates would increase our annual interest expense by approximately $6.6 million.

The table below provides information about our fixed rate and variable rate long-term debt agreements as of June 30, 2018:

	Expected Maturity for the Twelve-Month Periods Ending June 30,																Average
	(in millions)																Interest
	2019		2020		2021		2022		2023		Thereafter		Total		Fair Value		Rate
Fixed rate	$	1.4	$	1.4	$	—	$	—	$	400.0	$	755.0	$	1,157.8	$	1,143.8		5.0	%
Variable rate		6.6		6.6		6.6		6.6		6.6		623.2		656.2		657.0		3.9	%
Total debt	$	8.0	$	8.0	$	6.6	$	6.6	$	406.6	$	1,378.2	$	1,814.0	$	1,800.8

Other than the devaluation of the Argentine peso, discussed in Note 12 to the condensed consolidated financial statements, there have been no material changes in foreign currency exchange rate risk previously disclosed in “Quantitative and Qualitative Disclosures About Market Risk” in our Annual Report on Form 10-K for the year ended December 31, 2017 filed March 2, 2018.

As of June 30, 2018, we carried out an evaluation required by the Exchange Act, under the supervision and with the participation of our principal executive officer and principal financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rule 13a-15(e) of the Exchange Act. Based on this evaluation, our principal executive officer and principal financial officer concluded that, as of June 30, 2018, our disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms and were effective to provide reasonable assurance that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosures.

There have been no changes in our internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Exchange Act Rules 13a-15 that occurred during the quarter ended June 30, 2018 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Other than the recent developments noted at Note 16, there have been no material changes from legal proceedings previously reported under “Business – Legal Proceedings” in our Annual Report on Form 10-K for the year ended December 31, 2017 filed March 2, 2018.

There have been no material changes from risk factors previously disclosed in “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2017 filed March 2, 2018.

As required by the indentures governing the Company’s 5.125% Senior Notes and 4.875% Senior Notes, the Company has included in this filing, interim financial information for its subsidiaries that have been designated as unrestricted subsidiaries, as defined by the indentures. As required by these indentures, the Company has included an unaudited condensed consolidating balance sheet and unaudited condensed consolidating statements of income, comprehensive income and cash flows for the Company and its subsidiaries. The following supplementary schedules separately identify the Company’s restricted subsidiaries and unrestricted subsidiaries as required by the indentures.

	Restricted		Unrestricted
	Group		Group			Eliminations			Consolidated
Assets
Current assets
Cash and cash equivalents	$	471,072	$	33,623		$	—		$	504,695
Other current assets		242,473		(91,824	)		(8,224	)		142,425
Total current assets		713,545		(58,201	)		(8,224	)		647,120
Theatre properties and equipment, net		1,817,737		—			—			1,817,737
Other assets		1,847,599		507,734			(346,019	)		2,009,314
Total assets	$	4,378,881	$	449,533		$	(354,243	)	$	4,474,171
Liabilities and equity
Current liabilities
Current portion of long-term debt	$	6,595	$	1,389		$	—		$	7,984
Current portion of capital lease obligations		26,671		—			—			26,671
Accounts payable and accrued expenses		412,692		311			(8,224	)		404,779
Total current liabilities		445,958		1,700			(8,224	)		439,434
Long-term liabilities
Long-term debt, less current portion		2,012,393		1,389			(239,000	)		1,774,782
Capital lease obligations, less current portion		239,005		—			—			239,005
Other long-term liabilities and deferrals		474,191		62,997			—			537,188
Total long-term liabilities		2,725,589		64,386			(239,000	)		2,550,975
Commitments and contingencies
Equity		1,207,334		383,447			(107,019	)		1,483,762
Total liabilities and equity	$	4,378,881	$	449,533		$	(354,243	)	$	4,474,171

Note: “Restricted Group” and “Unrestricted Group” are defined in the indentures for the senior notes.

	Restricted			Unrestricted
	Group			Group			Eliminations		Consolidated
Revenues	$	1,669,024		$	—		$	—	$	1,669,024
Cost of operations										—
Theatre operating costs		1,201,795			—			—		1,201,795
General and administrative expenses		84,030			(6	)		—		84,024
Depreciation and amortization		128,685			—			—		128,685
Impairment of long-lived assets		3,379			—			—		3,379
Loss on disposal of assets and other		20,840			—			—		20,840
Total cost of operations		1,438,729			(6	)		—		1,438,723
Operating income		230,295			6			—		230,301
Other income (expense)		(78,544	)		37,691			—		(40,853	)
Income before income taxes		151,751			37,697			—		189,448
Income taxes		32,357			11,398			—		43,755
Net income		119,394			26,299			—		145,693
Less: Net income attributable to noncontrolling interests		485			—			—		485
Net income attributable to Cinemark USA, Inc.	$	118,909		$	26,299		$	—	$	145,208

Note: “Restricted Group” and “Unrestricted Group” are defined in the indentures for the senior notes.

	Restricted			Unrestricted
	Group			Group		Eliminations		Consolidated
Net income	$	119,394		$	26,299	$	—	$	145,693
Other comprehensive income (loss), net of tax
Other comprehensive income in equity method investments		—			20		—		20
Foreign currency translation adjustments		(56,044	)		—		—		(56,044	)
Total other comprehensive income (loss), net of tax		(56,044	)		20		—		(56,024	)
Total comprehensive income, net of tax		63,350			26,319		—		89,669
Comprehensive income attributable to noncontrolling interests		(485	)		—		—		(485	)
Comprehensive income attributable to Cinemark USA, Inc.	$	62,865		$	26,319	$	—	$	89,184

Note: “Restricted Group” and “Unrestricted Group” are defined in the indentures for the senior notes.

	Restricted			Unrestricted
	Group			Group			Eliminations			Consolidated
Operating activities
Net income	$	119,394		$	26,299		$	—		$	145,693
Adjustments to reconcile net income to cash provided by (used for) operating activities		162,782			(643	)		—			162,139
Changes in assets and liabilities		6,172			(34,359	)		—			(28,187	)
Net cash provided by (used for) operating activities		288,348			(8,703	)		—			279,645
Investing activities
Additions to theatre properties and equipment		(162,589	)		—			—			(162,589	)
Acquisitions of theatres in international markets, net of cash acquired		(11,508	)								(11,508	)
Proceeds from sale of theatre properties and equipment and other		2,135			—			—			2,135
Loans to affiliates		—			(19,000	)		19,000			—
(Investment in) return of investment from joint ventures and other, net		(19,896	)		429			—			(19,467	)
Net cash used for investing activities		(191,858	)		(18,571	)		19,000			(191,429	)
Financing activities
Dividends paid to parent		(74,350	)		—			—			(74,350	)
Borrowings from affiliates		19,000			—			(19,000	)		—
Repayments of long-term debt		(3,298	)		—			—			(3,298	)
Payment of debt issue costs		(5,103	)		—			—			(5,103	)
Payments on capital leases		(12,377	)		—			—			(12,377	)
Other		(3,609	)		—			—			(3,609	)
Net cash used for financing activities		(79,737	)		—			(19,000	)		(98,737	)
Effect of exchange rate changes on cash and cash equivalents		(7,199	)		—			—			(7,199	)
Increase (decrease) in cash and cash equivalents		9,554			(27,274	)		—			(17,720	)
Cash and cash equivalents:
Beginning of year		461,518			60,897			—			522,415
End of year	$	471,072		$	33,623		$	—		$	504,695

Note: “Restricted Group” and “Unrestricted Group” are defined in the indentures for the senior notes.

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Texas		75-2206284
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

3900 Dallas Parkway
Suite 500
Plano, Texas		75093
(Address of principal executive offices)		(Zip Code)

			Page
PART I. FINANCIAL INFORMATION

	Item 1.	Financial Statements	4

		Condensed Consolidated Balance Sheets as of June 30, 2018 and December 31, 2017 (unaudited)	4

		Condensed Consolidated Statements of Income for the three and six months ended June 30, 2018 and 2017 (unaudited)	5

		Condensed Consolidated Statements of Comprehensive Income for the three and six months ended June 30, 2018 and 2017 (unaudited)	6

		Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2018 and 2017 (unaudited)	7

		Notes to Condensed Consolidated Financial Statements (unaudited)	8

	Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	38

	Item 3.	Quantitative and Qualitative Disclosures About Market Risk	50

	Item 4.	Controls and Procedures	50

PART II. OTHER INFORMATION

	Item 1.	Legal Proceedings	51

	Item 1A.	Risk Factors	51

	Item 5	Other Information	51

	Item 6.	Exhibits	56

SIGNATURES			57

Deferred Revenues	Deferred Revenue - NCM			Other Deferred Revenues ⁽¹⁾			Total
Balance at January 1, 2018	$	351,706		$	86,498		$	438,204
Impact of adoption of ASC Topic 606		(53,605	)		—			(53,605	)
Amounts recognized as accounts receivable		—			11,349			11,349
Cash received from customers in advance		—			53,398			53,398
Common units received from NCM (see Note 7)		5,012			—			5,012
Revenue recognized during period		(7,849	)		(64,996	)		(72,845	)
Foreign currency translation adjustments		—			(1,689	)		(1,689	)
Balance at June 30, 2018	$	295,264		$	84,560		$	379,824

	Twelve Months Ended June 30,
Remaining Performance Obligations	2019		2020		2021		2022		2023		Thereafter		Total
Deferred revenue - NCM	$	15,831	$	15,831	$	15,831	$	15,831	$	15,831	$	216,109	$	295,264
Deferred revenue - other		72,053		12,039		282		186		—		—		84,560
Total	$	87,884	$	27,870	$	16,113	$	16,017	$	15,831	$	216,109	$	379,824

	Three Months Ended				Six Months Ended
	June 28, 2018		June 29, 2017		June 28, 2018		June 29, 2017
Gross revenues	$	113,700	$	97,100	$	193,900	$	169,000
Operating income	$	40,100	$	28,300	$	51,100	$	33,400
Net income	$	25,000	$	15,400	$	22,000	$	7,500

	As of			As of
	June 28, 2018			December 28, 2017
Current assets	$	142,800		$	174,400
Noncurrent assets	$	758,800		$	758,300
Current liabilities	$	84,800		$	123,300
Noncurrent liabilities	$	943,500		$	925,400
Members deficit	$	(126,700	)	$	(116,000	)

	As of
	June 30, 2018		December 31, 2017
Current assets	$	51,546	$	56,296
Noncurrent assets	$	725,399	$	772,438
Current liabilities	$	63,982	$	59,153
Noncurrent liabilities	$	213,795	$	296,889
Members' equity	$	499,168	$	472,692

	Shares of			Weighted Average
	Restricted			Grant Date
	Stock			Fair Value
Outstanding at January 1, 2018		650,581		$	35.81
Granted		321,406		$	38.79
Vested		(242,945	)	$	31.16
Forfeited		(18,643	)	$	38.33
Outstanding at June 30, 2018		710,399		$	38.68
Unvested restricted stock at June 30, 2018		710,399		$	38.68

	Six Months Ended June 30,
	2018		2017
Compensation expense recognized by the Company during the period	$	4,342	$	3,901
Additional compensation expense recognized by Cinemark Holdings, Inc. during the period	$	456	$	393
Fair value of restricted shares held by Company employees that vested during the period	$	7,013	$	7,174
Fair value of restricted shares held by Cinemark Holdings, Inc.’s directors that vested during the period	$	802	$	917
Income tax benefit recognized upon vesting of restricted stock awards held by Company employees	$	1,550	$	2,247
Additional income tax benefit recognized upon vesting of restricted stock awards held by Cinemark Holdings, Inc.'s directors	$	201	$	386

	Number of
	Shares		Value at
	Vesting		Grant
at IRR of at least 7%		76,065	$	2,967
at IRR of at least 9.5%		152,129	$	5,934
at IRR of at least 13%		228,194	$	8,901

	U.S. Operating Segment		International Operating Segment			Total
Balance at January 1, 2018 ⁽¹⁾	$	1,174,041	$	110,038		$	1,284,079
Acquisition of theatres in Brazil ⁽²⁾		—		11,508			11,508
Foreign currency translation adjustments		—		(14,417	)		(14,417	)
Balance at June 30, 2018⁽¹⁾	$	1,174,041	$	107,129		$	1,281,170

For the six months ended December 31, 2018	$	2,661
For the twelve months ended December 31, 2019		5,152
For the twelve months ended December 31, 2020		5,310
For the twelve months ended December 31, 2021		3,574
For the twelve months ended December 31, 2022		3,207
Thereafter		12,545
Total	$	32,449

					Other
					Comprehensive
					Income (Loss) for the
	Exchange Rate as of				Six Months Ended
Country	June 30, 2018		December 31, 2017		June 30, 2018
Brazil		3.88		3.31	$	(34,511	)
Argentina		28.94		18.65		(16,896	)
Peru		3.28		3.24		(580	)
Chile		654.28		615.97		(4,372	)
All other						315
					$	(56,044	)

	As of		As of
Theatre Properties and Equipment-net	June 30, 2018		December 31, 2017
U.S.	$	1,465,915	$	1,439,168
Brazil		146,467		179,669
Other international countries		205,355		209,217
Total	$	1,817,737	$	1,828,054

Cinemark USA, Inc. term loan	$	656.2
Cinemark USA, Inc. 5.125% senior notes due 2022		400.0
Cinemark USA, Inc. 4.875% senior notes due 2023		755.0
Other	2.8
Total long-term debt	$	1,814.0
Less current portion		8.0
Subtotal long-term debt, less current portion	$	1,806.0
Less: Debt discounts and debt issuance costs, net of accumulated amortization		31.2
Long-term debt, less current portion, net of debt issuance costs	$	1,774.8

	Payments Due by Period
	(in millions)
			Less Than						After
Contractual Obligations	Total		One Year		1 - 3 Years		3 - 5 Years		5 Years
Long-term debt ⁽¹⁾	$	1,814.0	$	8.0	$	14.6	$	413.2	$	1,378.2
Scheduled interest payments on long-term debt⁽²⁾	$	437.4	$	82.6	$	164.2	$	148.9	$	41.7

		Page
Unaudited Condensed Consolidating Balance Sheet Information as of June 30, 2018		52

Unaudited Condensed Consolidating Statement of Income Information for the six months ended June 30, 2018		53

Unaudited Condensed Consolidating Statement of Comprehensive Income Information for the six months ended June 30, 2018		54

Unaudited Condensed Consolidating Statement of Cash Flows Information for the six months ended June 30, 2018		55

10.1		Limited Liability Company Agreement of FE Concepts, LLC dated as of April 20, 2018 (incorporated by reference to Exhibit 10.1 to Cinemark Holdings, Inc.’s Quarterly Report on Form 10-Q, File No. 001-33401, filed August 8, 2018).

10.2		Management Services Agreement by and between FE Concepts, LLC and Cinema Operations, L.L.C. dated as of April 20, 2018 (incorporated by reference to Exhibit 10.2 to Cinemark Holdings, Inc.’s Quarterly Report on Form 10-Q, File No. 001-33401, filed August 8, 2018).

10.3		Theatre Services Agreement by and between FE Concepts, LLC and CNMK Texas Properties, LLC dated as of April 20, 2018 (incorporated by reference to Exhibit 10.3 to Cinemark Holdings, Inc.’s Quarterly Report on Form 10-Q, File No. 001-33401, filed August 8, 2018).

*31.1		Certification of Mark Zoradi, Chief Executive Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

*31.2		Certification of Sean Gamble, Chief Financial Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

*32.1		Certification of Mark Zoradi, Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as added by Section 906 of the Sarbanes-Oxley Act of 2002.

*32.2		Certification of Sean Gamble, Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as added by Section 906 of the Sarbanes-Oxley Act of 2002.

* 101		Financial Statements from the quarterly report on Form 10-Q of Cinemark USA, Inc. for the quarter ended June 30, 2018, filed August 9, 2018, formatted in XBRL: (i) the Condensed Consolidated Balance Sheets, (ii) the Condensed Consolidated Statements of Income, (iii) the Condensed Consolidated Statements of Comprehensive Income, (iv) the Condensed Consolidated Statements of Cash Flows and (v) the Notes to Condensed Consolidated Financial Statements tagged as detailed text.

		CINEMARK USA, INC.
		Registrant

DATE:	August 9, 2018

		/s/Mark Zoradi
		Mark Zoradi
		Chief Executive Officer

		/s/Sean Gamble
		Sean Gamble
		Chief Financial Officer